Research Resources

Agency for Healthcare Research and Quality/DHHS

Deadline(s)

06/12/2013 , 10/12/2013 , 02/12/2014 , 06/12/2014 , 10/12/2014

Review

04/04/2013

Contact

Kay Anderson, PhD, Program URL

Agency for Healthcare Research and Quality (AHRQ) invites applications for the AHRQ PCOR Mentored Clinical Investigator Award (K08). The purpose of the award is to prepare qualified individuals for careers utilizing complex comparative effectiveness research (CER) methods to clinical and health systems PCOR issues, involving stakeholders, as appropriate, in the design, execution, and dissemination of the research. This FOA will utilize the K08 Clinical Investigator Award (CIA).

Agency for Healthcare Research and Quality/DHHS

Deadline(s)

06/12/2013 , 10/12/2013 , 02/12/2014 , 06/12/2014 , 10/12/2014

Review

04/04/2013

Contact

Kay Anderson, PhD, Program URL

Agency for Healthcare Research and Quality (AHRQ) invites applications for the AHRQ PCOR Mentored Research Scientist Development Award (K01). The purpose of the award is to prepare qualified individuals for careers utilizing complex comparative effectiveness research (CER) methods to clinical and health systems PCOR issues, involving stakeholders, as appropriate, in the design, execution, and dissemination of the research. This FOA will utilize the K01 Research Scientist Development Award - Research & Training.

Agency for Healthcare Research and Quality/DHHS

Deadline(s)

06/16/2013 , 10/16/2013

Review

05/10/2013

Contact

Lia Hotchkiss, M.P.H., Program URL

The sponsor encourages Small Research Grant (R03) applications, and expresses AHRQ portfolio priority areas of interest for ongoing small research projects. The R03 grant mechanism supports different types of health services research projects including pilot and feasibility studies; secondary analysis of existing data; small, self-contained research projects; development of research methodology; and, development of new research technology.

Alzheimer's Drug Discovery Foundation

Deadline(s)

01/08/2013 , 02/18/2013 , 05/22/2013 , 08/22/2013 , 11/21/2013

Review

01/14/2013

Contact

Diana Shineman, PhD, Program URL

The sponsor's Academic Drug Discovery and Development Program seeks to create and support innovative translational programs in academic medical centers and universities.

Patient-Centered Outcomes Research Institute (PCORI)

Deadline(s)

02/15/2013 , 06/15/2013 , 10/15/2013

Review

04/11/2013

Contact

info@pcori.org, Program URL

PCORI invites applications for projects that address critical decisions that face patients, their caregivers, and clinicians every day and with too little information. These decisions must be consequential, be occurring now without key evidence about the comparative effectiveness of two or more options, and patients/caregivers must benefit from new knowledge in ways that are clear and important. The premise of this research is that new knowledge will support critical choices by patients, caregivers, and their clinicians, not that it will deliver a verdict that will lead us to dictate a choice. This knowledge will provide insight about the comparative benefits and harms of the options and provide information about outcomes that are experienced by patients and important to patients. A total of up to $12.0 million is available.

National Institute on Aging/NIH/DHHS

Deadline(s)

06/05/2013 , 10/05/2013

Review

02/20/2013

Contact

Laurie M. Ryan, Ph.D., Program URL

The sponsors invite qualified investigators to submit research grant applications for pilot clinical trials using pharmacologic and/or behavioral interventions directed toward the prevention and treatment of the cognitive and behavioral symptoms of mild cognitive impairment (MCI), Alzheimer's disease (AD), and age-related cognitive decline. This FOA will use the NIH Research Project (R01) award mechanism.

Department of the Army

Deadline(s)

06/05/2013

Review

05/06/2013

Contact

cdmrp.pa@amedd.army.mil, Program URL

The ALSRP was established in 2007 to provide support for research of exceptional scientific merit aimed at preclinical assessment of therapeutics for amyotrophic lateral sclerosis (ALS). Appropriations for the ALSRP from FY07 through FY12 totaled $31.9 million (M). The FY13 appropriation is $7.5M. The goal of the ALSRP is to contribute to a cure for ALS by funding innovative preclinical research to develop new treatments for ALS.

Department of the Army

Deadline(s)

06/05/2013

Review

05/06/2013

Contact

help@cdmrp.org, Program URL

The ALSRP was established in 2007 to provide support for research of exceptional scientific merit aimed at preclinical assessment of therapeutics for amyotrophic lateral sclerosis (ALS). Appropriations for the ALSRP from FY07 through FY12 totaled $31.9 million (M). The FY13 appropriation is $7.5M. The goal of the ALSRP is to contribute to a cure for ALS by funding innovative preclinical research to develop new treatments for ALS.

Child Neurology Society

Deadline(s)

06/01/2013

Review

04/17/2013

Contact

nationaloffice@childneurologysociety.org, Program URL

The Child Neurology Society announces the 2012 Arnold P. Gold Foundation Humanism in Medicine Award. This prestigious award will be presented to a practicing child neurologist or developmental pediatrician of any age who has been nominated by their peers and selected by the Child Neurology Society Awards Committee.

Department of the Army

Deadline(s)

07/02/2013

Review

05/15/2013

Contact

help@cdmrp.org, Program URL

The ARP Idea Development Award supports the development of innovative, high-risk/high-reward research that could lead to critical discoveries or major advancements that will accelerate progress in improving outcomes for individuals with autism. This award mechanism is designed to support innovative ideas with the potential to yield impactful data and new avenues of investigation. Through the Idea Development Award, the ARP seeks to promote multidisciplinary collaborations (e.g., special education, biomedical science, preclinical research). Past experimental research in the ASD research field or in other developmental disorders is crucial to the Idea Development Award and will be evaluated.

Department of the Army

Deadline(s)

07/02/2013

Review

05/15/2013

Contact

help@cdmrp.org, Program URL

The ARP Pilot Award supports conceptually innovative, high-risk/high-reward research that could ultimately lead to critical discoveries or major advancements that will drive the field of ASD forward. Research projects should include a testable hypothesis based on a strong scientific rationale. This award is not intended to support the continuation of existing studies or the next logical extension and/or incremental step. The Pilot Award is designed to support innovative ideas with the potential to yield impactful data and new avenues of investigation. The existence of preliminary data suggests that the proposed research does not meet the intent of this award mechanism. Therefore, preliminary data are not allowed. The strength of the application should be based on sound scientific rationale and logical reasoning.

Society for Neuroscience

Deadline(s)

06/12/2013

Review

03/28/2013

Contact

awards@sfn.org, Program URL

The Bernice Grafstein Award recognizes individuals who are dedicated to promoting women's advancement in the field of neuroscience and who have made outstanding accomplishments in mentoring.

Alzheimer's Foundation of America

Deadline(s)

02/01/2013 , 08/01/2013

Review

01/16/2013

Contact

cleech@alzfdn.org, Program URL

AFA’s Bi-Annual Grant offers funding to AFA’s nonprofit member organizations for new or existing programs and services that improve the lives of those living with Alzheimer’s disease or a related dementia, and their families.

National Institute of Biomedical Imaging and Bioengineering/NIH/DHHS

Deadline(s)

06/05/2013 , 09/07/2013 , 10/05/2013

Review

03/08/2013

Contact

Dr. Christine Kelley, Director, Program URL

The sponsors invite applications for collaborations between the life and physical sciences that: 1) apply a multidisciplinary bioengineering approach to the solution of a biomedical problem; and 2) integrate, optimize, validate, translate or otherwise accelerate the adoption of promising tools, methods and techniques for a specific research or clinical problem in basic, translational, or clinical science and practice. An application may propose design-directed, developmental, discovery-driven, or hypothesis-driven research and is appropriate for small teams applying an integrative approach that can increase our understanding of and solve problems in biological, clinical or translational science. This program will use the NIH Research Project (R01) award mechanism.

National Human Genome Research Institute/NIH/DHHS

Deadline(s)

06/08/2013 , 07/08/2013

Review

04/15/2013

Contact

Jeffery A. Schloss, Ph.D., Program URL

National Human Genome Research Institute (NHGRI) and National Institute of Mental Health (NIMH) invite applications for the Centers of Excellence in Genomic Sciences (CEGS) program. The program establishes academic Centers for advanced genome research. Each CEGS grant supports a multi-investigator, interdisciplinary team to develop innovative genomic approaches to address a particular biomedical problem. A CEGS project will address a critical issue in genomic science or genomic medicine, proposing a solution that would be a very substantial advance. Thus, the research conducted at these Centers will entail substantial risk, balanced by outstanding scientific and management plans and very high potential payoff. A CEGS will focus on the development of novel technological or computational methods for the production or analysis of comprehensive data sets, or on a particular genome-scale biomedical problem, or on other ways to develop and use genomic approaches for understanding biological systems. Exploiting its outstanding scientific plan and team, each CEGS will nurture genomic science at its institution by facilitating the interaction of investigators from different disciplines, and by providing training to new investigators it will expand the pool of professional genomics scientists and engineers. Applicants to the CEGS program are required to submit a parallel application to the Limited Competition: Initiative to Maximize Research Education in Genomics (R25): Diversity Action Plan http://grants.nih.gov/grants/guide/pa-files/PAR-13-063.html. This FOA will utilize the Specialized P50 Center grant mechanism. DEADLINE NOTE: The deadline for receipt of optional letters of intent is June 8, 2013. The deadline for receipt of full applications is July 8, 2013. This program will expire on July 9, 2013.

National Institute of Nursing Research/NIH/DHHS

Deadline(s)

05/07/2013 , 06/05/2013 , 09/07/2013 , 10/05/2013

Review

02/18/2013

Contact

Dr. Linda S. Weglicki, Ph.D., RN, MSN, Program URL

The sponsor invites applications for research to improve self-management and quality of life in children and adolescents with chronic illnesses. Children diagnosed with a chronic illness and their families have a life-long responsibility for self-management, to maintain and promote health and prevent complications. Biobehavioral studies of children in the context of family and family-community dynamics are encouraged. Research related to biological/technological factors, as well as, sociocultural, environmental, and behavioral mechanisms that contribute to successful and ongoing self-management of chronic illnesses in children is also encouraged. This FOA is restricted to studies of chronic illnesses in children and adolescents ages 8 to 21 grouped by developmental stages according to the discretion of the investigator. This program will use the NIH Research Project (R01) award mechanism.

National Institute of Nursing Research/NIH/DHHS

Deadline(s)

05/07/2013 , 06/16/2013 , 09/07/2013 , 10/16/2013 , 01/07/2014

Review

02/19/2013

Contact

Dr. Linda S. Weglicki, Ph.D., RN, MSN, Program URL

The sponsor invites applications for research to improve self-management and quality of life in children and adolescents with chronic illnesses. Children diagnosed with a chronic illness and their families have a life-long responsibility for self-management, to maintain and promote health and prevent complications. Biobehavioral studies of children in the context of family and family-community dynamics are encouraged. Research related to biological/technological factors, as well as, sociocultural, environmental, and behavioral mechanisms that contribute to successful and ongoing self-management of chronic illnesses in children is also encouraged. This FOA is restricted to studies of chronic illnesses in children and adolescents ages 8 to 21 grouped by developmental stages according to the discretion of the investigator. This program will use the NIH Small Research Grant (R03) award mechanism.

National Institute of Nursing Research/NIH/DHHS

Deadline(s)

05/07/2013 , 06/16/2013 , 09/07/2013 , 10/16/2013

Review

02/18/2013

Contact

Dr. Linda S. Weglicki, Ph.D., RN, MSN, Program URL

The sponsor invites applications for research to improve self-management and quality of life in children and adolescents with chronic illnesses. Children diagnosed with a chronic illness and their families have a life-long responsibility for self-management, to maintain and promote health and prevent complications. Biobehavioral studies of children in the context of family and family-community dynamics are encouraged. Research related to biological/technological factors, as well as, sociocultural, environmental, and behavioral mechanisms that contribute to successful and ongoing self-management of chronic illnesses in children is also encouraged. This FOA is restricted to studies of chronic illnesses in children and adolescents ages 8 to 21 grouped by developmental stages according to the discretion of the investigator. This program will use the NIH Exploratory/Developmental (R21) grant mechanism.

Dana (Charles A.) Foundation, Inc.

Deadline(s)

Ongoing

Review

02/15/2013

Contact

Mary M. Lucas, Program URL

Translational researchers apply for support to test promising therapies from animal model research in a small number of patients with devastating, currently untreatable, brain diseases. Also supported are studies to develop ethical guidelines for clinical brain research, and prognostic data based on treatment outcomes in patients with severe brain injuries or disorders. Deadline(s): Researchers interested in being considered to receive an invitation to apply to this program are welcome to send a brief (maximum two-page, 11-point font) description of the proposed research along with an NIH-style abbreviated CV to Mary M. Lucas at mlucas@dana.org. Requests will be reviewed on a rolling basis. Those investigators chosen to submit full proposals will be notified and provided with further instructions.

DePuy, Inc.

Deadline(s)

Ongoing

Review

03/18/2013

Contact

Program URL

Codman supports a variety of educational programs that are of interest to the Company, including continuing medical education (CME) events hosted by providers accredited by the Accreditation Council for Continuing Medical Education (ACCME); non-CME events that avoid off-label discussion of Codman products; NeuroEndovascular fellowship grants; travel grants for fellows and qualifying residents; grand rounds; and other education programs. Each request is evaluated on the individual programs merits, and all requests must be reviewed by the Codman Education Grant Committee for approval. DEADLINE NOTE: Requests should be submitted to the company at least eight weeks before the program to be funded begins.

McDonnell (James S.) Foundation

Deadline(s)

Ongoing

Review

02/19/2013

Contact

info@jsmf.org, Program URL

The Foundation offers Collaborative Activity Awards to initiate interdisciplinary discussions on problems or issues, to help launch interdisciplinary research networks, or to fund communities of researchers/practitioners dedicated to developing new methods, tools, and applications of basic research to applied problems. Deadline(s): There are no deadlines for this grant type. Applicants should submit a letter of inquiry. Letters of inquiry can be submitted at any time during the year, and must be submitted electronically to: collaborative@jsmf.org

Directorate for Biological Sciences/NSF

Deadline(s)

07/16/2013 , 07/14/2014

Review

04/17/2013

Contact

Daphne G. Fautin, Program URL

The Collections in Support of Biological Research (CSBR) Program provides funds: for improvements to secure, improve, and organize collections that are significant to the NSF BIO-funded research community; to secure collections-related data for sustained, accurate, and efficient accessibility of the collection to the biological research community; and to transfer collection ownership responsibilities.

Directorate for Biological Sciences/NSF

Deadline(s)

07/16/2013

Review

04/18/2013

Contact

Daphne G. Fautin, Program URL

The Collections in Support of Biological Research (CSBR) Program provides funds: for improvements to secure, improve, and organize collections that are significant to the NSF BIO-funded research community; to secure collections-related data for sustained, accurate, and efficient accessibility of the collection to the biological research community; and to transfer collection ownership responsibilities.

Patient-Centered Outcomes Research Institute (PCORI)

Deadline(s)

02/15/2013 , 06/15/2013 , 10/15/2013

Review

04/11/2013

Contact

pfa@pcori.org, Program URL

PCORI invites applications for projects that address critical decisions that face patients, their caregivers, and clinicians every day and with too little information. These decisions must be consequential, be occurring now without key evidence about the comparative effectiveness of two or more options, and patients/caregivers must benefit from new knowledge in ways that are clear and important. The premise of this research is that new knowledge will support critical choices by patients, caregivers, and their clinicians, not that it will deliver a verdict that will lead us to dictate a choice. This knowledge will provide insight about the comparative benefits and harms of the options and provide information about outcomes that are experienced by patients and important to patients. A total of up to $12.0 million is available.

American College of Neuropsychopharmacology

Deadline(s)

06/12/2013

Review

04/23/2013

Contact

Laura Hill, Program URL

The American College of Neuropsychopharmacology (ACNP) presents the Efron Award to an individual on the basis of outstanding basic research contributions to neuropsychopharmacology. The contributions may be preclinical or work that emphasizes the interface between basic and clinical research.

DePuy, Inc.

Deadline(s)

Ongoing

Review

03/18/2013

Contact

Program URL

DePuy Spine supports a variety of educational programs that are of interest to the Company, including continuing medical education (CME) events hosted by providers accredited by the Accreditation Council for Continuing Medical Education (ACCME); non-CME events that avoid off-label discussion of DePuy Spine products; fellowship grants; travel grants for spine fellows and qualifying residents; grand rounds; and other programs. Each request is evaluated on the individual program’s merits, and all requests must be reviewed by the DePuy Spine Education Grant Committee for approval. DEADLINE NOTE: Requests should be submitted to the sponsor at least six weeks before the program for which funding is to be used.

DePuy, Inc.

Deadline(s)

Ongoing

Review

03/18/2013

Contact

Program URL

A travel grant is intended to help defray the cost of conference attendance for a spine fellow or qualifying resident (in his/her last or second-to-last year of neurosurgical or orthopaedic residency) and may be provided to attend one appropriate clinical education program held in the continental United States each academic year. Programs must be consistent with AMA Guidelines, the AdvaMed Code, and any applicable state and local laws. The institution must select the traveler. DEADLINE NOTE: The request must be submitted by the institution’s program director at least 8 weeks prior to the meeting.

National Science Foundation

Deadline(s)

06/01/2013

Review

03/29/2013

Contact

Program URL

The National Science Foundation seeks proposals with the potential to transform neuroscience and cognitive science. The sponsor invites proposals that accelerate new integrative research across disciplines and across spatial and temporal scales of analysis in cognitive science and neuroscience. Such approaches will enhance our understanding of how the brain regulates the individual's biology, processes complex social and physical cues, and allows organisms to behave in and adapt to changing environments.

Muscular Dystrophy Association

Deadline(s)

06/15/2013

Review

03/22/2013

Contact

grants@mdausa.org, Program URL

The sponsor supports research aimed at developing treatments for the muscular dystrophies and related diseases of the neuromuscular system.

Office of Research Infrastructure Programs/NIH/DHHS

Deadline(s)

04/05/2013 , 05/07/2013 , 08/05/2013 , 09/07/2013 , 12/05/2013

Review

01/28/2013

Contact

Miguel Contreras, Program URL

Division of Comparative Medicine (DCM), Office of Research Infrastructure Programs (ORIP) invites applications for Small Business Technology Transfer (STTR) applications from small business concerns (SBCs) that propose innovative approaches to further develop, improve and facilitate the use of animal models and related biological materials to meet new biomedical challenges related to improvements in the health of humans and animals. This FOA will utilize the R41/R42 Small Business Technology Transfer (STTR) Grant - Phase I, Phase II, and Fast-Track applications.

National Institute of Mental Health/NIH/DHHS

Deadline(s)

05/07/2013 , 06/16/2013 , 09/07/2013 , 10/16/2013

Review

03/04/2013

Contact

David A. Chambers, Ph.D., Program URL

NIH and its participating Institutes and Centers invite applications that will identify, develop, evaluate and refine effective and efficient methods, systems, infrastructures, and strategies to disseminate and implement research-tested health behavior change interventions, evidence-based prevention, early detection, diagnostic, treatment and management, and quality of life improvement services, and data monitoring and surveillance reporting tools into public health and clinical practice settings that focus on patient outcomes. This program will use the NIH Small Research Grant (R03) award mechanism.

National Institute of Mental Health/NIH/DHHS

Deadline(s)

05/07/2013 , 06/16/2013 , 09/07/2013 , 10/16/2013

Review

03/04/2013

Contact

David A. Chambers, Ph.D., Program URL

NIH and its participating Institutes and Centers invite applications that will identify, develop, evaluate and refine effective and efficient methods, systems, infrastructures, and strategies to disseminate and implement research-tested health behavior change interventions, evidence-based prevention, early detection, diagnostic, treatment and management, and quality of life improvement services, and data monitoring and surveillance reporting tools into public health and clinical practice settings that focus on patient outcomes. This program will use the NIH Exploratory/Developmental (R21) grant mechanism.

American Psychological Association

Deadline(s)

06/01/2013

Review

03/22/2013

Contact

Suzanne Wandersman, Program URL

The sponsor presents an award to recognize excellent psychologists who are at early stages of their research careers. For the 2014 program, nominations of persons who received doctoral degrees during and since 2004 are being sought in these five areas: Animal learning and behavior, comparative; Cognition and human learning; Developmental psychology; Health psychology; Psychopathology.

National Institute on Alcohol Abuse and Alcoholism/NIH/DHHS

Deadline(s)

05/07/2013 , 06/05/2013 , 09/07/2013 , 10/05/2013

Review

02/20/2013

Contact

Dr. Lawrence Baizer, Program URL

The National Institute on Alcohol Abuse and Alcoholism (NIAAA) invites applications proposing to conduct mechanistic studies on the effects of adolescent binge alcohol consumption on synaptic maturation and myelin formation in the developing brain. This FOA will use the NIH Research Project (R01) award mechanism.

National Institute on Alcohol Abuse and Alcoholism/NIH/DHHS

Deadline(s)

05/07/2013 , 06/16/2013 , 09/07/2013 , 10/16/2013

Review

02/20/2013

Contact

Dr. Lawrence Baizer, Program URL

The National Institute on Alcohol Abuse and Alcoholism (NIAAA) invites applications proposing to conduct mechanistic studies on the effects of adolescent binge alcohol consumption on synaptic maturation and myelin formation in the developing brain. This program will use the NIH Exploratory/Developmental (R21) grant mechanism.

American Epilepsy Society

Deadline(s)

08/05/2013

Review

05/09/2013

Contact

Cheryl Tubby, Program URL

The sponsor provides two awards of $10,000 each. These awards will be made to active scientists and clinicians working in all aspects of epilepsy.

Science

Deadline(s)

06/15/2013

Review

04/09/2013

Contact

Maryrose Madrid, Program URL

The sponsor awards a prize to a young scientist for the most outstanding neurobiological research based on methods of molecular and cell biology conducted by him/her during the past three years.

Musculoskeletal Transplant Foundation

Deadline(s)

09/01/2013

Review

05/09/2013

Contact

Program URL

This is a multi-year program for any researcher who has previously been funded by a foundation or a federal agency and has published in a peer-reviewed journal as a Principal investigator.

Agency for Healthcare Research and Quality/DHHS

Deadline(s)

06/16/2013 , 10/16/2013

Review

05/10/2013

Contact

Angela Nunley, Program URL

The sponsor provides support for short-term preparatory, pilot or feasibility studies that will inform larger scale real world health IT implementation and use or the conduct of more comprehensive health IT implementation research. This program will use the NIH Exploratory/Developmental (R21) grant mechanism.

Food & Drug Administration

Deadline(s)

01/15/2013 , 04/15/2013 , 07/15/2013 , 10/15/2013

Review

05/10/2013

Contact

Lisa Ko Grants, Management Specialist, Program URL

The sponsor invites applications for support of scientific conferences clearly aligned with the FDA mission. This FOA will utilize the R13 Support for Conferences and Scientific Meetings award mechanism.

National Institute of Nursing Research/NIH/DHHS

Deadline(s)

05/07/2013 , 06/05/2013 , 09/07/2013 , 10/05/2013

Review

02/18/2013

Contact

Lois A. Tully, Ph.D., Program URL

The sponsors invite applications to expand basic and translational research, including intervention research, on the types, nature, and functional consequences of focal or specific cognitive deficits experienced by persons with central nervous system disorders. The Office of Behavioral and Social Sciences Research (OBSSR) joins this FOA as part of its efforts to promote research on the behavioral and social aspects of health and illness. However, only participating ICs will provide direct grant support under this FOA. This program will use the NIH Research Project (R01) award mechanism.

National Institute of Nursing Research/NIH/DHHS

Deadline(s)

05/07/2013 , 06/16/2013 , 09/07/2013 , 10/16/2013

Review

02/19/2013

Contact

Lois A. Tully, Ph.D., Program URL

The sponsors invite applications to expand basic and translational research, including intervention research, on the types, nature, and functional consequences of focal or specific cognitive deficits experienced by persons with central nervous system disorders. The Office of Behavioral and Social Sciences Research (OBSSR) joins this FOA as part of its efforts to promote research on the behavioral and social aspects of health and illness. However, only participating ICs will provide direct grant support under this FOA. This program will use the NIH Small Research Grant (R03) award mechanism.

National Institute of Nursing Research/NIH/DHHS

Deadline(s)

05/07/2013 , 06/16/2013 , 09/07/2013 , 10/16/2013

Review

02/18/2013

Contact

Lois A. Tully, Ph.D., Program URL

The sponsors invite applications to expand basic and translational research, including intervention research, on the types, nature, and functional consequences of focal or specific cognitive deficits experienced by persons with central nervous system disorders. The Office of Behavioral and Social Sciences Research (OBSSR) joins this FOA as part of its efforts to promote research on the behavioral and social aspects of health and illness. However, only participating ICs will provide direct grant support under this FOA. This program will use the NIH Exploratory/Developmental (R21) grant mechanism.

Fogarty International Center/NIH/DHHS

Deadline(s)

06/24/2013 , 07/24/2013

Review

03/13/2013

Contact

Jeanne McDermott, Program URL

National Institutes of Health (NIH) invites applications for research training programs to strengthen the HIV research capacity at low- and middle-income country (LMIC) institutions. Each application should propose a training program that will build or strengthen research capacity in an applicant-defined HIV-related scientific topic at an identified LMIC institution. This FOA will utilize the NIH D43 International Research Training Grant award mechanism.

American Heart Association (Founders Affiliate)

Deadline(s)

07/19/2013

Review

05/01/2013

Contact

Program URL

The American Heart Association (AHA) Founders Affiliate provides grants to support highly promising beginning scientists in their progress toward independence by encouraging and adequately funding research projects that can serve to bridge the gap between completion of research training and readiness for successful competition as an independent investigator.

Gordon Research Conferences

Deadline(s)

Ongoing

Review

04/05/2013

Contact

Program URL

The sponsor provides seminar opportunities for graduate students, post-docs, and other scientists with comparable levels of experience and education come together in a highly-stimulating and non-intimidating environment to discuss their current research and build informal networks with their peers that may lead to a lifetime of collaboration and scientific achievement. A variety of funding opportunities are available for participants. DEADLINE NOTE: There are a number of Gordon Research Seminars held each year. All Gordon Research Conferences and Gordon Research Seminars have an application deadline. The standard deadline is four weeks prior to the conference but some Conferences may implement an earlier deadline. The sponsor advises applicants to check the online program of the Conference they are interested in attending for the specific deadline. Applicants are encouraged to contact the Conference Chair directly to request financial assistance.

W. M. Keck Foundation

Deadline(s)

05/01/2013 , 11/01/2013

Review

04/11/2013

Contact

MedRsch@wmkeck.org, Program URL

The Medical Research Program seeks to advance the frontiers of the life sciences by supporting basic research that is high-risk and had the potential to transform its field. Successful projects are distinctive and novel in their approach to problems, push the edge of their field or question the prevailing paradigm. Past grants have been awarded to major research universities, medical schools and independent research institutions to support pioneering biological research, including the development of promising new technologies, instrumentation or methodologies.

Cure Parkinsons Trust

Deadline(s)

Ongoing

Review

03/29/2013

Contact

helen@cureparkinsons.org.uk, Program URL

The Cure Parkinson’s Trust funds laboratory or clinical research projects with the potential to advance knowledge that might lead to a cure for Parkinson’s disease, or that represent a substantial advance in treatment (for example, novel approaches to treatment, or new methods of treatment delivery). DEADLINE NOTE: The Charity accepts grant applications at any time, but holds four meetings annually to consider and prioritize projects for funding, in February, May, July and November.

Dr. G. Clifford and Florence B. Decker Foundation

Deadline(s)

05/01/2013 , 09/01/2013 , 11/01/2013

Review

03/04/2013

Contact

Gerald E. Putnam, Executive Director, Program URL

The sponsor provides assistance to charitable organizations, focusing primarily on educational, medical and medical research institutions, and cultural and human service organizations providing principal service to the residents of Broome County, New York. This assistance is in the form of grants that may be used for capital projects or new and innovative projects and programs.

Patrick P. Lee Foundation

Deadline(s)

04/15/2013 , 07/15/2013 , 10/15/2013

Review

04/12/2013

Contact

info@patrickpleefoundation.org, Program URL

The sponsor supports nonprofit organizations in Western New York and South Florida in the areas of; education, behavioral health, medical care/research, and human/community services. The foundation welcomes collaboration with other grant makers and favors grant seekers with multiple sources of support.

Edward Mallinckrodt Jr. Foundation

Deadline(s)

08/01/2013

Review

04/12/2013

Contact

Thomas F. Deuel, M.D., President, Program URL

The sponsor provides support for the purpose of advancing knowledge in the various fields of medical and health research.

United Hospital Fund of New York

Deadline(s)

07/01/2013

Review

04/03/2013

Contact

Hollis Holmes, Program URL

The United Hospital Fund awards Health Care Improvement Grants to not-for-profit organizations to develop and evaluate innovative health care projects and conduct research and analysis of significant health systems issues that will shape the future of health care in New York City. The grants are intended to increase access to and use of appropriate, high quality, and efficient health care services, especially for low-income and other vulnerable persons. Grants are also available to support new and expanded volunteer programs that improve the quality of the experience of patients and their family caregivers, particularly for patients with chronic disease, in both the inpatient and ambulatory settings.

Centers for Medicare and Medicaid Services/DHHS

Deadline(s)

06/28/2013

Review

05/16/2013

Contact

InnovationAwards@cms.hhs.gov, Program URL

This is the second round of an initiative that will fund applicants who propose new payment and service delivery models that will provide better health, better health care, and lower costs through improved quality for Medicare, Medicaid, and Children’s Health Insurance Program (CHIP)enrollees. Applicants will propose new service delivery models along with the design of corresponding new payment models. If their applications are funded, awardees will be required to implement the service delivery models at the start of the three-year cooperative agreement period and submit a fully developed new Medicare, Medicaid, or CHIP payment model by the end of the cooperative agreement period. The Centers for Medicare & Medicaid Services (CMS), at its discretion and consistent with the requirements of Section 1115A of the Social Security Act, may further develop one or more of these payment and service delivery models and open them to participation through a subsequent solicitation. Successful applicants will demonstrate that they can implement a model that improves quality of care and reduces cost within the first six months of the award and delivers net savings to CMS within three years. DEADLINE NOTE: Letters of intent are due on June 28, 2013. Applications are due on August 15, 2013.

International Neural Network Society

Deadline(s)

06/01/2013

Review

04/18/2013

Contact

nns@reesgroupinc.com, Program URL

The Hebb Award recognizes achievement in biological learning in the field of neural networks.

International Neural Network Society

Deadline(s)

06/01/2013

Review

04/18/2013

Contact

inns@reesgroupinc.com, Program URL

The Helmholtz Award recognizes achievement in sensation/perception in the field of neural networks.

National Institute on Drug Abuse/NIH/DHHS

Deadline(s)

05/07/2013 , 06/16/2013 , 09/07/2013 , 10/16/2013

Review

02/27/2013

Contact

Steven Grant, Ph.D., Program URL

National Institute on Drug Abuse (NIDA) invites applications to facilitate the entry of investigators to the area of neuroimaging, including both new investigators and established investigators seeking to adopt neuroimaging methodologies in their research programs. This program will use the NIH Small Research Grant (R03) award mechanism.

Office of Research Infrastructure Programs/NIH/DHHS

Deadline(s)

08/05/2013 , 09/07/2013 , 12/05/2013

Review

05/09/2013

Contact

Jean Richelsen, Program URL

The sponsors invite applications for Small Business Technology Transfer (STTR) grants from small business concerns (SBCs) for that propose to develop or improve technologies for obtaining, characterizing and testing animal and human stem cells and their derivatives as models for stem cell-based regenerative medicine using animal models. The program is intended to support projects devoted to the creation of informative animal models for regenerative medicine, which will facilitate testing the safety and therapeutic potential of animal and human stem cells and their derivatives for pre-clinical evaluation. The initiative focuses on the following areas: 1) comparative analysis of animal and human stem cells to provide information for selection of the most predictive and informative model systems; 2) development of new technologies for stem cells and their derivatives, including production, characterization and transplantation; and 3) improvement of animal disease models for stem cell-based therapeutic applications. The ultimate objective of these efforts should be to provide commercial products and technologies that can help develop future clinical therapies. This FOA will utilize the R41/R42 Small Business Technology Transfer (STTR) Grant - Phase I, Phase II, and Fast-Track applications.

Office of Research Infrastructure Programs/NIH/DHHS

Deadline(s)

06/05/2013 , 10/05/2013

Review

02/18/2013

Contact

Oleg Mirochnitchenko, Ph.D., Program URL

The sponsors invite applications aimed at characterizing animal stem cells and improving existing, and creating new, animal models for human disease conditions. The intent of this initiative is to facilitate the use of stem cell-based therapies for regenerative medicine. The initiative focuses on the following areas: 1) comparative analysis of animal and human stem cells to provide information for selection of the most predictive and informative model systems; 2) development of new technologies for stem cell characterization and transplantation; and 3) improvement of animal disease models for stem cell-based therapeutic applications. This FOA will use the NIH Research Project (R01) award mechanism.

Office of Research Infrastructure Programs/NIH/DHHS

Deadline(s)

06/16/2013 , 10/16/2013

Review

02/18/2013

Contact

Oleg Mirochnitchenko, Ph.D., Program URL

The sponsors invite applications aimed at characterizing animal stem cells and improving existing, and creating new, animal models for human disease conditions. The intent of this initiative is to facilitate the use of stem cell-based therapies for regenerative medicine. The initiative focuses on the following areas: 1) comparative analysis of animal and human stem cells to provide information for selection of the most predictive and informative model systems; 2) development of new technologies for stem cell characterization and transplantation; and 3) improvement of animal disease models for stem cell-based therapeutic applications. This FOA will use the NIH Exploratory/Developmental (R21) grant mechanism.

Agency for Healthcare Research and Quality/DHHS

Deadline(s)

07/31/2013 , 07/30/2014

Review

05/16/2013

Contact

Kay Anderson, Ph.D., Program URL

Agency for Healthcare Research and Quality (AHRQ) invites applications that propose to improve health outcomes by developing and disseminating evidence-based information to patients, clinicians, policy makers, and health care administrators, responding to their expressed needs about which clinical and health system design interventions are most effective for which patients under specific circumstances. This FOA will use the AHRQ Resource-Related Research Projects (R24) grant mechanism. DEADLINE NOTE: For applicants intending to submit an application for the December 19, 2013 receipt date, a request for permission to submit an application letter must be received by AHRQ by Wednesday, July 31, 2013. The letter from the Institution must be submitted electronically, and must be signed by the proposed Project Director/Principal Investigator(PD/PI) of the application and the Agency Authorizing Official. This FOA will expire on December 20, 2014.

Parkinson's UK

Deadline(s)

03/25/2013 , 05/20/2013 , 08/05/2013

Review

02/14/2013

Contact

Parkinson's UK, Program URL

Parkinson's UK offers grants of up to $30,000 for exploring original research ideas that could lead to exciting breakthroughs in the causes, treatment and cure of Parkinson's.

National Institute of Nursing Research/NIH/DHHS

Deadline(s)

10/05/2013 , 01/07/2014 , 02/05/2014 , 05/07/2014 , 06/05/2014 , 09/07/2014 , 10/05/2014

Review

04/26/2013

Contact

Donna Jo McCloskey, RN, PhD, Program Director, Program URL

National Institute of Nursing Research (NINR) invites applications for innovative measurement tools for community engaged research efforts. This FOA will use the NIH Research Project (R01) award mechanism. DEADLINE NOTE: Applications may be submitted to Grants.gov in response to this announcement on or after September 5, 2013 The deadlines for receipt of standard applications under this announcement are: February 5, June 5, and October 5 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on September 8, 2016.

National Institute of Nursing Research/NIH/DHHS

Deadline(s)

06/16/2013 , 10/16/2013 , 01/07/2014 , 02/16/2014 , 05/07/2014 , 09/07/2014 , 10/16/2014

Review

04/26/2013

Contact

Donna Jo McCloskey, RN, PhD, Program Director, Program URL

National Institute of Nursing Research (NINR) invites applications for innovative measurement tools for community engaged research efforts. This FOA will use the NIH Exploratory/Developmental (R21) grant mechanism. DEADLINE NOTE: Applications may be submitted to Grants.gov in response to this announcement on or after September 5, 2013 The deadlines for receipt of standard applications under this announcement are: February 5, June 5, and October 5 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on September 8, 2016.

National Institute of Nursing Research/NIH/DHHS

Deadline(s)

06/05/2013 , 09/07/2013 , 10/05/2013 , 01/07/2014 , 02/05/2014 , 05/07/2014 , 06/05/2014 , 09/07/2014 , 10/05/2014

Review

04/01/2013

Contact

Dr. Susan Marden, PhD, Program URL

National Institute of Nursing Research (NINR) and National Cancer Institute (NCI) invite applications to update the randomized control trial (RCT) design using novel research methods that are practical, innovative, and hold promise for producing more effective outcomes. Novel clinical research designs, applied to symptom management trials, may identify those treatment strategies that best alter the course of symptom burden in chronic illness by addressing the issues of varied treatment responses across patients, subject retention, and adherence to treatment regimens. This FOA will use the NIH Research Project (R01) award mechanism.

National Institute of Nursing Research/NIH/DHHS

Deadline(s)

06/25/2013 , 09/07/2013 , 10/25/2013 , 01/07/2014 , 02/25/2014 , 05/07/2014 , 06/25/2014 , 09/07/2014 , 10/25/2014

Review

04/01/2013

Contact

Dr. Susan Marden, PhD, Program URL

National Institute of Nursing Research (NINR) and National Cancer Institute (NCI) invite applications to update the randomized control trial (RCT) design using novel research methods that are practical, innovative, and hold promise for producing more effective outcomes. Novel clinical research designs, applied to symptom management trials, may identify those treatment strategies that best alter the course of symptom burden in chronic illness by addressing the issues of varied treatment responses across patients, subject retention, and adherence to treatment regimens. This FOA will use the NIH R15 Academic Research Enhancement Award (AREA) mechanism.

National Institute of Nursing Research/NIH/DHHS

Deadline(s)

06/16/2013 , 09/07/2013 , 10/16/2013 , 01/07/2014 , 02/16/2014 , 05/07/2014 , 06/16/2014 , 09/07/2014 , 10/16/2014

Review

04/01/2013

Contact

Dr. Susan Marden, PhD, Program URL

National Institute of Nursing Research (NINR) and National Cancer Institute (NCI) invite applications to update the randomized control trial (RCT) design using novel research methods that are practical, innovative, and hold promise for producing more effective outcomes. Novel clinical research designs, applied to symptom management trials, may identify those treatment strategies that best alter the course of symptom burden in chronic illness by addressing the issues of varied treatment responses across patients, subject retention, and adherence to treatment regimens. This FOA will use the NIH Exploratory/Developmental (R21) grant mechanism.

National Heart, Lung, and Blood Institute/NIH/DHHS

Deadline(s)

06/05/2013 , 09/07/2013 , 10/05/2013

Review

03/04/2013

Contact

David Gordon, M.D., Ph.D., Special Assistant for Clinical Studies, Program URL

National Heart, Lung, and Blood Institute (NHLBI) invites applications for investigator-initiated multi-site randomized controlled clinical trials. The trials may address any research question related to the mission and goals of the NHLBI and may test clinical or behavioral interventions. The FOA is appropriate for applications to conduct phase II and phase III randomized clinical trials where participants are recruited from multiple sites. Large-scale pragmatic trials (such as comparative effectiveness trials) as well as trials designed to test efficacy of an intervention are appropriate. The trials may randomize at the individual (patient) level or at a group level (e.g., randomization of clinics, schools, worksites, etc.). Clinical trials involving NHLBI mission-related rare diseases that require coordination across multiple clinical sites are also suitable for submission to this FOA. In any case, the trial should propose the most efficient study design to complete the specific aims. This program will use the NIH Research Project (R01) award mechanism.

Society for Neuroscience

Deadline(s)

06/19/2013

Review

03/28/2013

Contact

awards@sfn.org, Program URL

The Jacob P. Waletzky Award is given to a young scientist who has conducted research or plans to conduct research in the area of substance abuse and the brain and nervous system.

Society for Neuroscience

Deadline(s)

06/05/2013

Review

03/28/2013

Contact

awards@sfn.org, Program URL

The Career Development Award is given to recognize individuals for original and creative research.

American College of Neuropsychopharmacology

Deadline(s)

06/12/2013

Review

04/23/2013

Contact

Laura Hill, Program URL

The American College of Neuropsychopharmacology (ACNP) presents the Joel Elkes Research Award to a young scientist in recognition of an outstanding clinical contribution to neuropsychopharmacology.

American College of Neuropsychopharmacology

Deadline(s)

06/12/2013

Review

04/23/2013

Contact

Laura Hill, Program URL

The American College of Neuropsychopharmacology (ACNP) presents the Julius Axelrod Mentorship Award to an ACNP member who has made an outstanding contribution to neuropsychopharmacology by mentoring and developing young scientists into leaders in the field.

Society for Neuroscience

Deadline(s)

06/19/2013

Review

03/28/2013

Contact

awards@sfn.org, Program URL

The Julius Axelrod Prize was established to honor a scientist with distinguished achievements in the broad field of neuropharmacology (or a related area) and exemplary efforts in mentoring young scientists.

Fox (Michael J.) Foundation for Parkinson's Research

Deadline(s)

Ongoing

Review

02/18/2013

Contact

Program URL

Michael J. Fox Foundation for Parkinson’s Research (MJFF) seeks to support work that can significantly contribute to a better understanding of the gene/protein leucine-rich repeat kinase 2 (LRRK2), its relevance to Parkinson’s disease (PD) and effective ways to translate LRRK2 research into therapies for patients. Applicants may submit a proposal focused on a relevant area of LRRK2 for consideration of a one-year, $125,000 award.

Society for Neuroscience

Deadline(s)

06/12/2013

Review

03/28/2013

Contact

awards@sfn.org, Program URL

The Louise Hanson Marshall Special Recognition Award is presented at the Celebration of Women in Neuroscience Luncheon held during the Society for Neuroscience (SfN) annual meeting. The award is given to recognize an individual who has significantly promoted the professional development of women in neuroscience through teaching, organizational leadership, public advocacy, or other efforts that are not necessarily related to research.

Multiple Sclerosis International Federation

Deadline(s)

12/31/2013

Review

02/25/2013

Contact

Dhia Chandraratna, International Medical & Scientific Research Officer, Program URL

The sponsor provides grants to support the costs of organizing international meetings on MS-related research. The funds are intended to contribute towards the costs of organization, administration and hosting of meetings as well as participation and attendance at meetings.

New York State Office of Science, Technology, and Academic Research

Deadline(s)

Ongoing

Review

03/18/2013

Contact

NYSTARSupport@esd.ny.gov, Program URL

NYSTAR reviews and coordinates university requests for matching grants and letters of support for the Administration. These grants leverage resources from federal or private sources, including the National Science Foundation, the National Institutes of Health, businesses, industry consortiums, foundations, and other organizations. To qualify for a Matching Funds Grant, NYSTAR requires the research institution to meet a minimum 3:1 matching requirement of dollars coming to New York State, excluding institutional support. For every dollar an institution receives from NYSTAR, the institution must receive three dollars from sources outside the institution. Funds eligible for matching are those received by the institution from the granting entity and/or from private industry that will remain in New York State. Institutional and other state funds are not eligible to calculate the 3:1 matching funds requirement. The minimum matching funds that may be applied for from the State is $100,000 per year. State matching funds may be used for expenses including, but not limited to, salaries of the principal investigator and the research staff, equipment, materials, and supplies. DEADLINE NOTE: All requests must be submitted to NYSTAR at least 30 days prior to submittal to the federal or private funding source.

National Institute on Alcohol Abuse and Alcoholism/NIH/DHHS

Deadline(s)

10/05/2013 , 01/07/2014 , 02/05/2014 , 05/07/2014 , 06/05/2014 , 09/07/2014 , 10/05/2014 , 01/07/2015 , 02/05/2015 , 05/07/2015 , 06/05/2015 , 09/07/2015 , 10/05/2015 , 01/07/2016 , 02/05/2016 , 05/07/2016 , 06/05/2016 , 09/07/2016

Review

04/15/2013

Contact

Ivana Grakalic, Ph.D., Program URL

National Institute on Alcohol Abuse and Alcoholism (NIAAA) invites applications from institutions/organizations that propose to study neurobiological and behavioral mechanisms contributing to concurrent alcohol and nicotine co-addiction. This FOA will use the NIH Research Project (R01) award mechanism.

National Institute on Alcohol Abuse and Alcoholism/NIH/DHHS

Deadline(s)

10/05/2013 , 01/07/2014 , 02/05/2014 , 05/07/2014 , 06/05/2014 , 09/07/2014 , 10/05/2014

Review

04/29/2013

Contact

Ivana Grakalic, Ph.D., Program URL

National Institute on Alcohol Abuse and Alcoholism (NIAAA) invites applications from institutions/organizations that propose to study neurobiological and behavioral mechanisms contributing to concurrent alcohol and nicotine co-addiction. This FOA will use the NIH Research Project (R01) award mechanism. DEADLINE NOTE: Applications may be submitted to Grants.gov in response to this announcement on or after September 5, 2013. The deadlines for receipt of standard R01 applications under this announcement are: February 5, June 5, and October 5 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on September 8, 2016.

National Institute on Alcohol Abuse and Alcoholism/NIH/DHHS

Deadline(s)

10/16/2013 , 01/07/2014 , 02/16/2014 , 05/07/2014 , 06/16/2014 , 09/07/2014 , 10/16/2014 , 01/07/2015 , 02/16/2015 , 05/07/2015 , 06/16/2015 , 09/07/2015 , 10/16/2015 , 01/07/2016 , 02/16/2016 , 05/07/2016 , 06/16/2016 , 09/07/2016

Review

04/15/2013

Contact

Ivana Grakalic, Ph.D., Program URL

National Institute on Alcohol Abuse and Alcoholism (NIAAA) invites applications from institutions/organizations that propose to study neurobiological and behavioral mechanisms contributing to concurrent alcohol and nicotine co-addiction. This FOA will use the NIH Exploratory/Developmental (R21) grant mechanism.

National Institute on Alcohol Abuse and Alcoholism/NIH/DHHS

Deadline(s)

10/16/2013 , 01/07/2014 , 02/16/2014 , 05/07/2014 , 06/16/2014 , 09/07/2014 , 10/16/2014

Review

04/29/2013

Contact

Ivana Grakalic, Ph.D., Program URL

National Institute on Alcohol Abuse and Alcoholism (NIAAA) invites applications from institutions/organizations that propose to study neurobiological and behavioral mechanisms contributing to concurrent alcohol and nicotine co-addiction. This FOA will use the NIH Exploratory/Developmental (R21) grant mechanism. DEADLINE NOTE: Applications may be submitted to Grants.gov in response to this announcement on or after September 5, 2013. The deadlines for receipt of standard R01 applications under this announcement are: February 5, June 5, and October 5 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on September 8, 2016.

National Institute of Nursing Research/NIH/DHHS

Deadline(s)

06/05/2013 , 09/07/2013 , 10/05/2013

Review

03/04/2013

Contact

Dr. Susan Marden, Ph.D., Program Director, Program URL

The sponsors invite applications to stimulate and foster a wide range of basic, clinical, and translational studies on pain as they relate to the missions of these ICs. New advances are needed in every area of pain research, from the micro perspective of molecular sciences to the macro perspective of behavioral and social sciences. Although great strides have been made in some areas, such as the identification of neural pathways of pain, the experience of pain and the challenge of treatment have remained uniquely individual and unsolved. Furthermore, our understanding of how and why individuals transition to a chronic pain state after an acute injury is limited. Research to address these issues conducted by interdisciplinary and multidisciplinary research teams is strongly encouraged, as is research from underrepresented, minority, disabled, or women investigators. This FOA will use the NIH Research Project (R01) award mechanism.

National Institute of Nursing Research/NIH/DHHS

Deadline(s)

04/16/2013 , 04/16/2013 , 06/05/2013 , 09/07/2013 , 10/05/2013 , 01/07/2014 , 02/05/2014 , 05/07/2014 , 06/05/2014 , 09/07/2014 , 10/05/2014

Review

04/10/2013

Contact

Dr. Susan Marden, Ph.D., Program Director, Program URL

The sponsors invite applications to stimulate and foster a wide range of basic, clinical, and translational studies on pain as they relate to the missions of these ICs. New advances are needed in every area of pain research, from the micro perspective of molecular sciences to the macro perspective of behavioral and social sciences. Although great strides have been made in some areas, such as the identification of neural pathways of pain, the experience of pain and the challenge of treatment have remained uniquely individual and unsolved. Furthermore, our understanding of how and why individuals transition to a chronic pain state after an acute injury is limited. Research to address these issues conducted by interdisciplinary and multidisciplinary research teams is strongly encouraged, as is research from underrepresented, minority, disabled, or women investigators. This FOA will use the NIH Research Project (R01) award mechanism.

National Institute of Nursing Research/NIH/DHHS

Deadline(s)

06/16/2013 , 09/07/2013 , 10/16/2013

Review

02/25/2013

Contact

Dr. Susan Marden, Ph.D., Program Director, Program URL

The sponsors invite applications to stimulate and foster a wide range of basic, clinical, and translational studies on pain as they relate to the missions of these ICs. New advances are needed in every area of pain research, from the micro perspective of molecular sciences to the macro perspective of behavioral and social sciences. Although great strides have been made in some areas, such as the identification of neural pathways of pain, the experience of pain and the challenge of treatment have remained uniquely individual and unsolved. Furthermore, our understanding of how and why individuals transition to a chronic pain state after an acute insult is limited. Research to address these issues conducted by interdisciplinary and multidisciplinary research teams is strongly encouraged, as is research from underrepresented, minority, disabled, or women investigators. This program will use the NIH Small Research Grant (R03) award mechanism.

National Institute of Nursing Research/NIH/DHHS

Deadline(s)

09/07/2013 , 10/16/2013

Review

03/04/2013

Contact

Dr. Susan Marden, Ph.D., Program Director, Program URL

The sponsors invite applications to stimulate and foster a wide range of basic, clinical, and translational studies on pain as they relate to the missions of these ICs. New advances are needed in every area of pain research, from the micro perspective of molecular sciences to the macro perspective of behavioral and social sciences. Although great strides have been made in some areas, such as the identification of neural pathways of pain, the experience of pain and the challenge of treatment have remained uniquely individual and unsolved. Furthermore, our understanding of how and why individuals transition to a chronic pain state after an acute insult is limited. Research to address these issues conducted by interdisciplinary and multidisciplinary research teams is strongly encouraged, as is research from underrepresented, minority, disabled, or women investigators. This program will use the NIH Exploratory/Developmental (R21) grant mechanism.

National Institute of Nursing Research/NIH/DHHS

Deadline(s)

06/16/2013 , 09/07/2013 , 10/16/2013 , 01/07/2014 , 02/16/2014 , 05/07/2014 , 06/16/2014 , 09/07/2014 , 10/16/2014

Review

04/10/2013

Contact

Dr. Susan Marden, Ph.D., Program Director, Program URL

The sponsors invite applications to stimulate and foster a wide range of basic, clinical, and translational studies on pain as they relate to the missions of these ICs. New advances are needed in every area of pain research, from the micro perspective of molecular sciences to the macro perspective of behavioral and social sciences. Although great strides have been made in some areas, such as the identification of neural pathways of pain, the experience of pain and the challenge of treatment have remained uniquely individual and unsolved. Furthermore, our understanding of how and why individuals transition to a chronic pain state after an acute insult is limited. Research to address these issues conducted by interdisciplinary and multidisciplinary research teams is strongly encouraged, as is research from underrepresented, minority, disabled, or women investigators. This program will use the NIH Exploratory/Developmental (R21) grant mechanism.

National Institute of Diabetes and Digestive and Kidney Diseases/NIH/DHHS

Deadline(s)

06/05/2013 , 10/05/2013 , 02/05/2014 , 06/05/2014 , 10/05/2014

Review

03/28/2013

Contact

Corinne M. Silva, Ph.D., Program Director, Program URL

NIDDK, NHLBI and NICHD invite applications for novel research on how prenatal exposures contribute to the etiology of chronic diseases and health conditions later in life. The goal of this FOA is to stimulate research by leveraging existing birth cohorts to address targeted mechanistic questions regarding the normal and abnormal developmental origins of organ systems and/or diseases of interest to the participating NIH Institutes and Centers. This FOA will use the NIH Research Project (R01) award mechanism.

National Multiple Sclerosis Society

Deadline(s)

08/07/2013

Review

05/13/2013

Contact

Nicholas LaRocca, PhD, Program URL

The National MS Society welcomes applications for support of mentors and institutions that provide training of postdoctoral fellows in research related to multiple sclerosis rehabilitation which may serve to advance the mission of the Society.

National Institute of Arthritis & Musculoskeletal & Skin Diseases/NIH/DHHS

Deadline(s)

06/12/2013 , 10/12/2013

Review

02/21/2013

Contact

Amanda Taylor Boyce, Ph.D., Program URL

The sponsors invite applications for mentored career development awards for clinical scientist engaged in laboratory research. It is expected that this career development program will increase the number of investigators in basic, translational, and clinical research on muscular dystrophy, and will also increase the quality of their research and training. Diseases for this program announcement include, but are not limited to, Duchenne, myotonic, facioscapulohumeral, and congenital muscular dystrophies. This FOA will utilize the K08 grant mechanism.

National Institute of Arthritis & Musculoskeletal & Skin Diseases/NIH/DHHS

Deadline(s)

06/12/2013 , 10/12/2013

Review

02/21/2013

Contact

Amanda Taylor Boyce, Ph.D., Program URL

The sponsors invite applications for mentored career development awards for clinical scientist engaged in patient-oriented research (POR). It is expected that this career development program will increase the number of investigators in basic, translational, and clinical research on muscular dystrophy, and will also increase the quality of their research and training. Diseases for this program announcement include, but are not limited to, Duchenne, myotonic, facioscapulohumeral, and congenital muscular dystrophies. This FOA will utilize the K23 grant mechanism.

National Institutes of Health/DHHS

Deadline(s)

05/07/2013 , 06/12/2013 , 09/07/2013 , 10/12/2013

Review

03/13/2013

Contact

Lester Gorelic, Ph.D., Program URL

The sponsor provides support to mid-career health-professional doctorates or equivalent who are typically at the Associate Professor level or the equivalent for protected time to devote to patient-oriented research (POR) and to act as research mentors primarily for clinical residents, clinical fellows and/or junior clinical faculty. This FOA will utilize the NIH Midcareer Investigator Award in Patient-Oriented Research (K24) mechanism.

Society for Neuroscience

Deadline(s)

06/12/2013

Review

03/28/2013

Contact

awards@sfn.org, Program URL

The Mika Salpeter Lifetime Achievement Award recognizes an individual with outstanding career achievements in neuroscience who has also significantly promoted the professional advancement of women in neuroscience.

Department of the Army

Deadline(s)

06/18/2013

Review

05/07/2013

Contact

help@cdmrp.org, Program URL

The MSRP was initiated in 2009 to provide support for research of exceptional scientific merit. Appropriations for the MSRP from FY09 through FY12 totaled $18.1 million (M). The FY13 appropriation is $5M. The objective of the FY13 MSRP is to support pioneering ideas and high-impact research relevant to the prevention, etiology, pathogenesis, assessment, and treatment of multiple sclerosis (MS) to achieve the program’s vision to prevent the occurrence; cure, reverse, or slow the progression; and lessen the personal and societal impact of MS. To be considered for funding, applications for the FY13 MSRP Idea Development Award must address at least one of the following Focus Areas: Biological basis of symptoms and their management (e.g., cognition, quality of life, rehabilitation, restoration of function, pathophysiological basis of pain); Mechanistic studies of environmental risk factors; Endocrinological influences on disease activity and progression; and Co-morbidities and their impact on disease activity and progression. DEADLINE NOTE: Pre-application Submission Deadline is 5:00 p.m. Eastern time (ET), June 18, 2013. The invited application submission deadline is 11:59 p.m. ET, September 17, 2013.

Brain and Behavior Research Foundation

Deadline(s)

06/01/2013

Review

04/23/2013

Contact

grants@bbrfoundation.org, Program URL

The Foundation’s NARSAD Distinguished Investigator Grant Program offers up to $100,000 for a (1) year period and is intended for established scientists who maintain peer reviewed competitively funded scientific programs.

National Institute of Arthritis & Musculoskeletal & Skin Diseases/NIH/DHHS

Deadline(s)

03/20/2013 , 07/19/2013 , 11/20/2013

Review

02/21/2013

Contact

Marie Mancini, Ph.D., Program URL

National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) invites applications to stimulate and facilitate the entry of promising new investigators into research on arthritis and musculoskeletal and skin diseases and injuries. This FOA will provide support for pilot research that is likely to lead to a subsequent individual research project grant (R01). Clinical trials of any phase will not be supported by this FOA. This program will use the NIH Small Research Grant (R03) award mechanism.

National Institute on Drug Abuse/NIH/DHHS

Deadline(s)

05/07/2013 , 05/25/2013 , 09/07/2013

Review

02/27/2013

Contact

Jag Khalsa, Ph.D., Program URL

The sponsor invites applications for broadly based investigative efforts with a well-defined central focus or object to address critical issues in drug abuse and addiction involving neuroscience, behavior, prevention, treatment, epidemiology, etiology, health services, HIV/AIDS or other drug abuse-related research areas. This FOA will utilize the NIH Program Project (P01) grant mechanism.

National Institutes of Health/DHHS

Deadline(s)

02/16/2013 , 05/07/2013 , 06/16/2013 , 09/07/2013 , 10/16/2013

Review

01/17/2013

Contact

grantsinfo@nih.gov, Program URL

The Exploratory/Developmental Grant (R21) mechanism is intended to encourage exploratory and developmental research projects by providing support for the early and conceptual stages of these projects. These studies may involve considerable risk but may lead to a breakthrough in a particular area, or to the development of novel techniques, agents, methodologies, models, or applications that could have a major impact on a field of biomedical, behavioral, or clinical research. This PA will use the NIH Exploratory/Developmental Research Grant (R21) award mechanism. <S2S>

National Institutes of Health/DHHS

Deadline(s)

05/07/2013 , 06/12/2013 , 09/07/2013 , 10/12/2013 , 01/07/2014 , 02/12/2014 , 05/07/2014 , 06/12/2014 , 09/07/2014

Review

03/26/2013

Contact

grantinfo@nih.gov, Program URL

The sponsors offer support for the Pathway to Independence (PI) Award program, which is designed to increase and maintain a strong cohort of new and talented NIH-supported independent investigators. The award program is designed to facilitate a timely transition from a mentored postdoctoral research position to a stable independent research position with independent NIH or other independent research support at an earlier stage than is currently the norm. This program will use the NIH combination K99/R00 funding mechanism.

National Institute of Arthritis & Musculoskeletal & Skin Diseases/NIH/DHHS

Deadline(s)

06/12/2013 , 10/12/2013

Review

02/21/2013

Contact

Amanda Taylor Boyce, Ph.D., Program URL

The sponsors invite applications for mentored career development awards for clinical scientist engaged in laboratory research. It is expected that this career development program will increase the number of investigators in basic, translational, and clinical research on muscular dystrophy, and will also increase the quality of their research and training. Diseases for this program announcement include, but are not limited to, Duchenne, myotonic, facioscapulohumeral, and congenital muscular dystrophies. This FOA will utilize the K99 grant mechanism.

National Institutes of Health/DHHS

Deadline(s)

02/16/2013 , 05/07/2013 , 06/16/2013 , 09/07/2013 , 10/16/2013

Review

01/17/2013

Contact

grantsinfo@nih.gov, Program URL

The National Institutes of Health (NIH) Investigator-Initiated Small Grant (R03) funding opportunity supports small research projects that can be carried out in a short period of time with limited resources. Investigator-initiated research, also known as unsolicited research, is research funded as a result of an investigator submitting a research grant application to NIH in an investigator’s area of interest and competency. The R03 grant mechanism supports different types of projects including pilot and feasibility studies; secondary analysis of existing data; small, self-contained research projects; development of research methodology; and development of new research technology. This program will use the NIH Small Research Grant (R03) award mechanism.

National Institute of Neurological Disorders and Stroke/NIH/DHHS

Deadline(s)

05/07/2013 , 06/05/2013 , 09/07/2013

Review

03/28/2013

Contact

Peter R. Gilbert, Sc.M., Program URL

The sponsor invites applications for exploratory clinical trials to the National Institute of Neurological Disorders and Stroke (NINDS). The trials must address research questions related to the mission and goals of the NINDS and may evaluate drugs, biologics, devices, or surgical, behavioral or rehabilitation therapies. Information about the mission, strategic plans and research interests of the NINDS can be found at the NINDS website (http:\\www.ninds.nih.gov). This FOA will use the NIH Research Project (R01) award mechanism.

National Institute of Neurological Disorders and Stroke/NIH/DHHS

Deadline(s)

05/07/2013 , 06/05/2013 , 09/07/2013

Review

03/28/2013

Contact

Scott Janis, Ph.D., Program URL

The sponsor invites applications for investigator-initiated, multi-site, randomized, controlled Phase III clinical trials to the National Institute of Neurological Disorders and Stroke (NINDS). The trials may address any research question related to the mission and goals of the NINDS. Information about the mission, strategic plan and research interests of the NINDS can be found at the NINDS website (http://www.ninds.nih.gov/). This FOA will utilize the Cooperative Agreement (U01) grant mechanism.

National Institute of Mental Health/NIH/DHHS

Deadline(s)

02/22/2013 , 06/24/2013 , 10/24/2013

Review

01/15/2013

Contact

Linda Brady, Ph.D., Director, Program URL

NIMH, NIAAA and NIDA invite applications to create multidisciplinary research groups or partnerships for the discovery of pharmacological agents to treat and to study mental illness or drug or alcohol addiction. The objectives of this program are to: accelerate innovative drug discovery; develop pharmacologic tools for basic and clinical research on mental disorders, or drug or alcohol addiction; develop and validate models for evaluating novel therapeutics for mental disorders; and support early phase human clinical testing to rapidly assess the safety and efficacy of promising drug candidates and new indications for IND-ready agents for the treatment of mental disorders or alcohol addiction. The National Institute of Mental Health (NIMH), the National Institute on Drug Abuse (NIDA), and the National Institute on Alcohol Abuse and Alcoholism (NIAAA) encourage applications to advance the discovery, preclinical development, and proof of concept testing of new, rationally-based candidate agents to treat mental disorders or drug or alcohol addiction, and to develop novel ligands as tools to further characterize existing or to validate new drug targets. Partnerships between academia and industry are strongly encouraged. This FOA will utilize the NIH U19 Research Program ? Cooperative Agreements award mechanisms.

National Institute of Mental Health/NIH/DHHS

Deadline(s)

02/22/2013 , 06/24/2013 , 10/24/2013

Review

01/15/2013

Contact

Linda Brady, Ph.D., Director, Program URL

NIMH, NIAAA and NIDA invite applications to create multidisciplinary research groups or partnerships for the discovery of pharmacological agents to treat and to study mental illness or drug or alcohol addiction. The objectives of this program are to: accelerate innovative drug discovery; develop pharmacologic tools for basic and clinical research on mental disorders, or drug or alcohol addiction; develop and validate models for evaluating novel therapeutics for mental disorders; and support early phase human clinical testing to rapidly assess the safety and efficacy of promising drug candidates and new indications for IND-ready agents for the treatment of mental disorders or alcohol addiction. The National Institute of Mental Health (NIMH), the National Institute on Drug Abuse (NIDA), and the National Institute on Alcohol Abuse and Alcoholism (NIAAA) encourage applications to advance the discovery, preclinical development, and proof of concept testing of new, rationally-based candidate agents to treat mental disorders or drug or alcohol addiction, and to develop novel ligands as tools to further characterize existing or to validate new drug targets. Partnerships between academia and industry are strongly encouraged. This FOA will utilize the NIH U19 Research Program Cooperative Agreements award mechanisms.

National Institute of Mental Health/NIH/DHHS

Deadline(s)

09/25/2013

Review

05/09/2013

Contact

David M. Panchision, Ph.D., Program URL

National Institute of Mental Health (NIMH) invites applications to participate in the National Cooperative Reprogrammed Cell Research Groups (NCRCRG) program. The purpose of the NCRCRG program is to create multidisciplinary research groups, in partnership with academia and industry, to use patient-derived reprogrammed cells to develop validated platforms for identifying novel targets and developing new therapeutics or diagnostic tools to reduce the burden of mental illness. The collaborations will be pre-competitive, meaning that they lie at the interface between basic academic research and proprietary industrial research and involve cooperation between groups that might otherwise be competitors, with a focus on optimizing tools and measures needed for successful translational research. The Funding Opportunity Announcement (FOA) encourages applications to further develop promising cellular differentiation/characterization protocols and/or disease-relevant assays using patient-derived reprogrammed cells (e.g., induced pluripotent stem cells or iPSCs, induced neuronal cells or iNCs). Critical features of these applications should be (1) a strong emphasis on developing methodology that is robust and replicable across several performance sites, and (2) cross-paradigm validation to yield predictive value for pathophysiology. This FOA will utilize the NIH U19 Research Program ? Cooperative Agreements award mechanism.

American Heart Association

Deadline(s)

07/18/2013

Review

04/09/2013

Contact

apply@heart.org, Program URL

The National Established Investigator Award supports mid-career investigators with unusual promise that have an established record of accomplishments. Candidates must have a demonstrated commitment to cardiovascular or cerebrovascular science as indicated by prior publication history and scientific accomplishments.

American Heart Association

Deadline(s)

07/18/2013

Review

04/09/2013

Contact

apply@heart.org, Program URL

The National Innovative Research Grant supports highly innovative, high-risk, high-reward research that could ultimately lead to critical discoveries or major advancements that will accelerate the field of cardiovascular and stroke research.

National Institute on Aging/NIH/DHHS

Deadline(s)

05/07/2013 , 05/25/2013

Review

02/11/2013

Contact

Marilyn M. Miller, Ph.D., Program Director, Program URL

National Institute on Aging (NIA) invites applications specific to the analysis of whole exome and genome sequencing data provided by the National Human Genome Research Institute Large-Scale Sequencing Program for the Alzheimer's disease research community. This FOA will utilize the NIH U19 Research Program Cooperative Agreements mechanism.

National Institute on Aging/NIH/DHHS

Deadline(s)

05/07/2013 , 05/25/2013

Review

02/11/2013

Contact

Marilyn M. Miller, Ph.D., Program Director, Program URL

National Institute on Aging (NIA) invites applications specific to the analysis of whole exome and genome sequencing data provided by the National Human Genome Research Institute Large-Scale Sequencing Program for the Alzheimer's disease research community. This FOA will utilize the NIH U19 Research Program Cooperative Agreements mechanism.

Office of Special Education & Rehabilitative Services/Department of Education

Deadline(s)

07/08/2013

Review

05/09/2013

Contact

Marlene Spencer, Program URL

The purpose of the Disability and Rehabilitation Research Projects and Centers Program is to plan and conduct research, demonstration projects, training, and related activities, including international activities, to develop methods, procedures, and rehabilitation technology that maximize the full inclusion and integration into society, employment, independent living, family support, and economic and social self-sufficiency of individuals with disabilities, especially individuals with the most severe disabilities, and to improve the effectiveness of services authorized under the Rehabilitation Act of 1973, as amended (Rehabilitation Act).

NIH/NINDS

Deadline(s)

Ongoing

Review

N/A

Contact

Christine Annis, Program URL

NeuroNEXT, a NINDS initiative to conduct Phase II trials in neurological conditions, receives proposals from academics, foundations and industry. All proposals are evaluated for mission relevance and institute priority by NINDS and for network feasibility by the NeuroNEXT Executive Committee (NEC). All proposals which are found to be mission relevant, feasible and of sufficient institute priority are referred to protocol working groups (PWG) for development of grant applications. The NINDS, NEC and PWG do not make any determination as to scientific merit; applicants should be aware that the fact that NeuroNEXT is submitting a proposal for review is no guarantee of funding approval. The scientific review of the proposal occurs after the grant application has been submitted for peer- and council-review. Funding decisions are made based on the results of those reviews.

Department of the Army

Deadline(s)

06/27/2013

Review

05/06/2013

Contact

help@cdmrp.org, Program URL

The NFRP was initiated in 1996 to provide support for research of exceptional scientific merit that promotes the understanding, diagnosis, and treatment of neurofibromatosis (NF) including neurofibromatosis type 1 and type 2 and schwannomatosis. Appropriations for the NFRP from FY96 through FY12 totaled $242.85 million (M). The FY13 appropriation is $15M. The vision of the FY13 NFRP is to decrease the clinical impact of NF. Toward this end, the NFRP seeks to support innovative, high-impact research that will foster new directions for and address neglected issues in NF research; sponsor multidisciplinary and multi-institutional collaborations that will bring new perspectives to the field; foster the next generation of NF investigators; promote translational and clinical studies to move promising ideas from bench to bedside; develop a balanced portfolio of meritorious research related to all aspects of NF1, NF2, and schwannomatosis.

Department of the Army

Deadline(s)

06/27/2013

Review

05/08/2013

Contact

help@cdmrp.org, Program URL

The NFRP was initiated in 1996 to provide support for research of exceptional scientific merit that promotes the understanding, diagnosis, and treatment of neurofibromatosis (NF) including neurofibromatosis type 1 and type 2 and schwannomatosis. Appropriations for the NFRP from FY96 through FY12 totaled $242.85 million (M). The FY13 appropriation is $15M. The vision of the FY13 NFRP is to decrease the clinical impact of NF. Toward this end, the NFRP seeks to support innovative, high-impact research that will foster new directions for and address neglected issues in NF research; sponsor multidisciplinary and multi-institutional collaborations that will bring new perspectives to the field; foster the next generation of NF investigators; promote translational and clinical studies to move promising ideas from bench to bedside; develop a balanced portfolio of meritorious research related to all aspects of NF1, NF2, and schwannomatosis.

Department of the Army

Deadline(s)

06/27/2013

Review

05/06/2013

Contact

help@cdmrp.org, Program URL

The NFRP was first funded in 1996 to provide support for research of exceptional scientific merit that promotes the understanding, diagnosis, and treatment of neurofibromatosis (NF) including neurofibromatosis type 1 and type 2 and schwannomatosis. Appropriations for the NFRP from FY96 through FY12 totaled $242.85 million (M). The FY13 appropriation is $15M. The vision of the FY13 NFRP is to decrease the clinical impact of NF. Toward this end, the NFRP seeks to support innovative, high-impact research that will foster new directions for and address neglected issues in NF research; sponsor multidisciplinary and multi-institutional collaborations that will bring new perspectives to the field; foster the next generation of NF investigators; promote translational and clinical studies to move promising ideas from bench to bedside; develop a balanced portfolio of meritorious research related to all aspects of NF1, NF2, and schwannomatosis.

Department of the Army

Deadline(s)

06/27/2013

Review

05/06/2013

Contact

help@cdmrp.org, Program URL

The NFRP was initiated in 1996 to provide support for research of exceptional scientific merit that promotes the understanding, diagnosis, and treatment of neurofibromatosis (NF) including neurofibromatosis type 1 and type 2 and schwannomatosis. Appropriations for the NFRP from FY96 through FY12 totaled $242.85 million (M). The FY13 appropriation is $15M. The vision of the FY13 NFRP is to decrease the clinical impact of NF. Toward this end, the NFRP seeks to: support innovative, high-impact research that will foster new directions for and address neglected issues in NF research; sponsor multidisciplinary and multi-institutional collaborations that will bring new perspectives to the field; foster the next generation of NF investigators; promote translational and clinical studies to move promising ideas from bench to bedside; develop a balanced portfolio of meritorious research related to all aspects of NF1, NF2, and schwannomatosis.

National Institute on Alcohol Abuse and Alcoholism/NIH/DHHS

Deadline(s)

05/07/2013 , 06/05/2013 , 09/07/2013 , 10/05/2013

Review

02/20/2013

Contact

Changhai Cui, Ph.D., Program URL

The sponsor invites applications that propose study the neuroimmune mechanisms of alcohol related disorders. Studies supported by this FOA will provide fundamental insights of neuroimmune mechanisms underlying brain functional and behavioral changes induced by alcohol. This FOA will use the NIH Research Project (R01) award mechanism.

National Institute on Alcohol Abuse and Alcoholism/NIH/DHHS

Deadline(s)

05/07/2013 , 06/05/2013 , 09/07/2013 , 10/05/2013 , 01/07/2014

Review

03/26/2013

Contact

Changhai Cui, Ph.D., Program URL

The sponsor invites applications that propose study the neuroimmune mechanisms of alcohol related disorders. Studies supported by this FOA will provide fundamental insights of neuroimmune mechanisms underlying brain functional and behavioral changes induced by alcohol. This FOA will use the NIH Research Project (R01) award mechanism. DEADLINE NOTE: The deadlines for receipt of standard R01 applications under this announcement are: February 5, June 5, and October 5 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on January 8, 2014.

National Institute on Alcohol Abuse and Alcoholism/NIH/DHHS

Deadline(s)

05/07/2013 , 06/05/2013 , 09/07/2013 , 10/16/2013

Review

02/21/2013

Contact

Changhai Cui, Ph.D., Program URL

The sponsor invites applications that propose study the neuroimmune mechanisms of alcohol related disorders. Studies supported by this FOA will provide fundamental insights of neuroimmune mechanisms underlying brain functional and behavioral changes induced by alcohol. This program will use the NIH Exploratory/Developmental (R21) grant mechanism.

National Institute on Drug Abuse/NIH/DHHS

Deadline(s)

05/07/2013 , 06/05/2013 , 09/07/2013

Review

02/28/2013

Contact

Nancy S. Pilotte, Ph.D., Chief, Program URL

The sponsor invites applications that are relevant to the understanding of the process(es) and mechanisms underlying drug abuse and addiction, including use, dependence, addiction, withdrawal, and treatment, and may be conducted using model systems, animals, and/or humans. This program will use the NIH Research Project (R01) award mechanism.

National Institute on Drug Abuse/NIH/DHHS

Deadline(s)

05/07/2013 , 06/16/2013 , 09/07/2013

Review

02/27/2013

Contact

Nancy S. Pilotte, Ph.D., Chief, Program URL

The sponsor invites applications that are relevant to the understanding of the process(es) and mechanisms underlying drug abuse and addiction, including use, dependence, addiction, withdrawal, and treatment, and may be conducted using model systems, animals, and/or humans. This program will use the NIH Exploratory/Developmental (R21) grant mechanism.

National Institute on Drug Abuse/NIH/DHHS

Deadline(s)

05/07/2013 , 06/16/2013 , 09/07/2013

Review

02/27/2013

Contact

Nancy S. Pilotte, Ph.D., Chief, Program URL

The sponsor invites applications that are relevant to the understanding of the process(es) and mechanisms underlying drug abuse and addiction, including use, dependence, addiction, withdrawal, and treatment, and may be conducted using model systems, animals, and/or humans. This program will use the NIH Small Research Grant (R03) award mechanism.

Society for Neuroscience

Deadline(s)

06/05/2013

Review

03/28/2013

Contact

awards@sfn.org, Program URL

The Next Generation Award recognizes SfN chapter members who have made outstanding contributions to public communication, outreach, and education about neuroscience.

Greater Rochester Health Foundation

Deadline(s)

08/06/2013

Review

05/14/2013

Contact

Sharon Legette-Sobers, Program URL

The Greater Rochester Health Foundation provides support for projects that have the maximum potential to positively impact the community’s health in the areas of prevention and health care delivery within their service area which includes; Genesee, Livingston, Monroe, Ontario, Orleans, Seneca, Wayne, Wyoming and Yates.

National Institute of Child Health and Human Development/NIH/DHHS

Deadline(s)

06/05/2013 , 10/05/2013 , 02/05/2014 , 06/05/2014 , 10/05/2014

Review

04/26/2013

Contact

Melissa A. Parisi, MD, PhD, Program URL

National Institute of Child Health and Human Development (NICHD) and National Institute of Mental Health (NIMH) invite applications that propose to develop informative outcome measures for use in clinical trials for individuals with intellectual and developmental disabilities (IDD). This FOA will address a significant need in the field, one that is especially apparent in efforts to develop pharmacological treatments for these populations. This FOA will focus ongoing clinical and translational research on a neglected area essential for therapy and pharmacological treatment development. This FOA will use the NIH Research Project (R01) award mechanism.

American College of Neuropsychopharmacology

Deadline(s)

06/12/2013

Review

04/23/2013

Contact

Laura Hill, Program URL

The Paul Hoch Distinguished Service Award is presented by the ACNP when a member has made unusually significant contributions to the College.

Directorate for Social, Behavioral and Economic Sciences/NSF

Deadline(s)

06/17/2013 , 08/01/2013 , 02/03/2014

Review

03/29/2013

Contact

Betty Tuller, Program URL

Support is provided for research in perception, action and cognition.

National Multiple Sclerosis Society

Deadline(s)

08/15/2013

Review

05/14/2013

Contact

Jennifer Stark, PhD, Program URL

The National MS Society seeks to attract and train promising young investigators and doctors into the field of MS by supporting the training of postdoctoral fellows in studies related to MS. The Society supports fundamental as well as applied studies, non-clinical or clinical in nature, including projects in patient management, care and rehabilitation.

National Institute of Child Health and Human Development/NIH/DHHS

Deadline(s)

06/05/2013 , 10/05/2013 , 06/05/2014 , 10/05/2014

Review

04/26/2013

Contact

Melissa A. Parisi, MD, PhD, Program URL

National Institute of Child Health and Human Development (NICHD) invites applications from institutions/ organizations addressing preclinical research in model organisms of neurodevelopmental disorders. Applications submitted to this FOA should propose to develop, validate, and/or calibrate outcome measures, surrogate markers, and biomarkers in model organisms that can inform and effectively translate to human clinical trials for individuals with intellectual and developmental disabilities (IDD). In addition, applications may propose to conduct rigorous, controlled and standardized preclinical animal trials designed for safety, toxicity, and efficacy prediction or to perform an independent validation of efficacy in animals prior to human clinical trials. The goal of this FOA is to accelerate and improve the preclinical testing of candidate treatments and therapeutic compounds in order to move promising new drug therapies into clinical trials. Potential applicants may be interested in the FOA Outcome Measures For Use In Treatment Trials of Individuals with Intellectual and Developmental Disabilities. This FOA will use the NIH Research Project (R01) award mechanism.

National Institute on Aging/NIH/DHHS

Deadline(s)

05/10/2013 , 06/11/2013

Review

03/04/2013

Contact

Creighton H. Phelps, Ph.D., Program URL

National Institute on Aging (NIA) invites applications for support of Alzheimer's Disease Research Centers (ADRCs). These centers are designed to support and conduct research on Alzheimer's disease (AD), to serve as shared research resources that will facilitate research in AD and related disorders, distinguish them from the processes of normal brain aging and mild cognitive impairment (MCI), provide a platform for training, collect biospecimens useful for clinical research, develop novel techniques and methodologies, and translate these research findings into better diagnostic, prevention, treatment and care strategies. This FOA will utilize the NIH P50 Specialized Center mechanism.

National Institute on Aging/NIH/DHHS

Deadline(s)

08/01/2013

Review

04/19/2013

Contact

Wen G. Chen, Ph.D., Program URL

National Institute on Aging (NIA) invites applications for broad applications of optogenetic tools for research on normal and/or pathological aging of neural systems including sensory, motor, cognitive, emotional, autonomic, sleep, and neurovascular, or Alzheimer's disease (AD), as well as to encourage additional development of aging and AD specific optogenetic tools. This FOA will use the NIH Research Project (R01) award mechanism. DEADLINE NOTE: Applications may be submitted to Grants.gov in response to this announcement on or after July 1, 2013. The deadline for receipt of optional letters of intent is July 1, 2013. The deadline for receipt of full applications is August 1, 2013, by 5:00 PM local time of applicant organization.

National Institute of Allergy and Infectious Diseases/NIH/DHHS

Deadline(s)

06/11/2013 , 07/11/2013

Review

03/11/2013

Contact

Joana Roe, B.A., Program URL

NIH participating Centers and Institutes invite applications to renew the clinical research sites (CRSs) of the Multicenter AIDS Cohort Study (MACS) and continue support for clinical, epidemiologic and basic research on a cohort of men who report sex with men (MSM). The MACS will continue to characterize the long-term, natural and treated history of HIV infection in MSM, provide insight into the clinical epidemiology of HIV, and further our understanding of predictors of disease among HIV positive MSM. The MACS CRSs will also transition to a rolling cohort design to replace existing cohort members who die or otherwise are permanently lost to follow-up. Due to the demonstrated capacity to recruit and retain this unique population, the depth of data and specimens collected over decades, and the need for continued follow-up, this competition will be limited to the current four clinical awardee institutions for the MACS CRSs. This program will use the NIH U01 Research Project Cooperative Agreements award mechanism.

National Institute of Arthritis & Musculoskeletal & Skin Diseases/NIH/DHHS

Deadline(s)

02/07/2014

Review

04/23/2013

Contact

Gayle E. Lester, Ph.D., Program URL

National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) invites applications for research awards designed to develop new and evaluate existing clinical trial outcome instruments/measures to better assess the benefits (efficacy and effectiveness) and adverse impacts of therapies employed to treat diseases and injuries of interest to the NIAMS. This FOA seeks to facilitate the development and subsequent evaluation of both new and existing clinically relevant and patient-important outcome instruments/measures that could be further tested in existing or novel clinical trials designed to gain widespread acceptance and application in the diagnosis, monitoring, treatment or cure of diseases and injuries of interest to the NIAMS. Outcome instruments/measures should be as generalizable as possible with the ultimate aim to impact patient care. This program will use the NIH U01 Research Project Cooperative Agreements award mechanism. DEADLINE NOTE: Applications may be submitted to Grants.gov in response to this announcement on or after January 7, 2014. The deadline for receipt of optional letters of intent is January 7, 2014. The deadline for receipt of full applications is February 7, 2014, by 5:00 PM local time of applicant organization.

National Cancer Institute/NIH/DHHS

Deadline(s)

04/30/2013 , 05/31/2013

Review

02/22/2013

Contact

Rodrigo Chuaqui, M.D., Program Director, Program URL

National Cancer Institute (NCI) invites applications for Collaborative (currently "Cooperative") Human Tissue Network (CHTN) awards from institutions/teams capable of contributing to the mission of CHTN by: (1) providing prospective investigator-defined procurement of high-quality malignant, benign, diseased, and uninvolved (normal adjacent) tissues and fluids from patients throughout North America and elsewhere; (2) assisting individual investigators with regard to specific specimen needs of their research; (3) assisting in developing and disseminating knowledge on high quality practices for successfully operating a biospecimen repository; and (4) educating the community about the importance of the availability of high quality human tissue specimens for medical research. Depending on their profile and capabilities, applicants must indicate whether they propose to function as the CHTN adult biospecimen division or the pediatric specimen division. Nonetheless, it will be acceptable for an adult biospecimen division, if capable, to contribute pediatric samples for networked requests. This FOA will utilize the NIH UM1 Multi-component Research Project Cooperative Agreements award mechanism.

National Institute on Drug Abuse/NIH/DHHS

Deadline(s)

12/11/2013

Review

03/04/2013

Contact

Minda Lynch, Ph.D., Program URL

NIH Basic Behavioral & Social Science Opportunity Network (OppNet) on behalf of its constituent organizations invites applications for short-term mentored career enhancement (K18) awards in basic behavioral and social sciences research (b-BSSR). This funding mechanism will support development of research capability in b-BSSR, with specific emphasis on cross-training and establishing collaborations between researchers with expertise in animal models of basic behavioral and social processes and those studying similar or related processes in human subjects. Basic research using any non-human species or with human subjects in laboratory- or field-based settings is appropriate for this FOA. Eligible candidates for this K18 will be either: (a) scientists conducting b-BSSR in animal models who seek training in the study of similar or related behavioral or social processes in humans; or (b) investigators conducting b-BSSR in human subjects who seek training in the study of similar or related processes in animal models. Candidates may be at any rank or level of research/academic development beyond three years of postdoctoral experience. This FOA will utilize the NIH K18 Career Enhancement Award mechanism.

National Institute of General Medical Sciences/NIH/DHHS

Deadline(s)

04/30/2013 , 05/30/2013

Review

03/05/2013

Contact

Alexandra M. Ainsztein, Ph.D., Program URL

National Institute of General Medical Sciences (NIGMS) invites applications for inter-disciplinary collaborative projects to advance studies of macromolecular interactions and their relationship to function in cells. These collaborations are designed to integrate additional research strategies into NIGMS' research base of laboratories specializing in macromolecular function in living systems. Grantees may use this funding opportunity to (i) complement each other's capabilities (for example, in biochemistry, genetics, chemistry, or pharmacology), where the innovation is in the biology rather than in the technology; (ii) apply proven technologies that are technically challenging, expensive, or not yet widely used in cell biology and allied fields (for example, mass spectrometry, high-throughput screening); (iii) develop, pilot, evaluate, and/or apply emerging technologies (for example, super resolution light microscopy); (iv) carry out feasibility studies or upstream research and development of new technological concepts that are unproven, but potentially useful for study of macromolecular interactions. This FOA invites unconventional research strategies, including exploratory, descriptive, and statistical approaches, and encourages discovery and hypothesis generation as research objectives. This FOA will use the NIH Research Project (R01) award mechanism.

National Institute of General Medical Sciences/NIH/DHHS

Deadline(s)

04/30/2013 , 05/30/2013

Review

03/05/2013

Contact

Alexandra M. Ainsztein, Ph.D., Program URL

National Institute of General Medical Sciences (NIGMS) invites applications for inter-disciplinary collaborative research networks to advance studies of macromolecular interactions and their relationship to function in cells. These networks are designed to integrate additional research strategies into NIGMS' research base of laboratories specializing in macromolecular function in living systems. Investigators may use this funding opportunity to (i) complement each other's capabilities (for example, in biochemistry, genetics, chemistry, or pharmacology), where the innovation is in the biology rather than in the technology; (ii) apply proven technologies that are technically challenging, expensive, or not yet widely used in cell biology and allied fields (for example, mass spectrometry, high-throughput screening); (iii) develop, pilot, evaluate, and/or apply emerging technologies (for example, super resolution light microscopy); (iv) carry out feasibility studies or upstream research and development of new technological concepts that are unproven, but potentially useful for study of macromolecular interactions. This FOA invites unconventional research strategies, including exploratory, descriptive, and statistical approaches, and encourages discovery and hypothesis generation as research objectives. This FOA will use the NIH U54 Specialized Center- Cooperative Agreements award mechanism.

National Institute on Aging/NIH/DHHS

Deadline(s)

07/17/2013

Review

04/22/2013

Contact

Jennifer Moore, Ph.D., R.N., Program URL

Agency for Healthcare Research and Quality (AHRQ) invites applications to support the career development of post-doctoral and junior research and clinical doctorate faculty scholars in comparative effectiveness research methods, applied to patient-centered outcomes. This FOA will utilize the K12 The Mentored

Agency for Healthcare Research and Quality/DHHS

Deadline(s)

07/31/2013

Review

05/02/2013

Contact

Jennifer E. Moore, Ph.D., R.N., Program URL

Agency for Healthcare Research and Quality (AHRQ) invites applications to identify strategies to engage stakeholders through shared decision making that can be used to effectively implement interventions specific to health care delivery systems, clinicians, and/or patients that focus on the reduction of racial/ethnic healthcare disparities in under-resourced settings. The effective strategies will incorporate the translation, dissemination, and implementation of patient-centered outcomes research (PCOR) findings for racial/ethnic minority populations. Successful applicants are required to demonstrate an ability to leverage the capacities of relevant and diverse stakeholders in their strategies to reduce healthcare disparities in under-resourced settings. This FOA will utilize the U18 Research Demonstration Cooperative Agreement award mechanism. DEADLINE NOTE: Applications may be submitted to Grants.gov in response to this announcement on or after June 30, 2013. The deadline for receipt of optional letters of intent is June 14, 2013. The deadline for receipt of full applications is July 31, 2013, by 5:00 PM local time of applicant organization.

National Institute of Mental Health/NIH/DHHS

Deadline(s)

05/27/2013 , 06/27/2013

Review

03/11/2013

Contact

Michael Kozak, Ph.D. , Program URL

National Institute of Mental Health (NIMH) invites applications designed to develop innovative ways of understanding mental disorders through classifying patients in clinical studies on the basis of experimental research criteria rather than traditional diagnostic categories. This FOA will use the NIH Research Project (R01) award mechanism.

National Institute of Mental Health/NIH/DHHS

Deadline(s)

10/07/2013 , 11/07/2013

Review

03/13/2013

Contact

Susan T. Azrin, Ph.D., Program URL

National Institute of Mental Health (NIMH) invites applications for rigorous effectiveness testing of innovative services interventions designed to reduce the prevalence and magnitude of common modifiable health risk factors related to shortened lifespan in adults with severe mental illness (SMI), as well as in children and youth with serious emotional disturbances (SED). This FOA will use the NIH Research Project (R01) award mechanism.

National Institute of Mental Health/NIH/DHHS

Deadline(s)

10/18/2013

Review

04/16/2013

Contact

Amy B. Goldstein, Ph.D., Program URL

National Institute of Mental Health (NIMH) invites applications aimed at developing and determining, prospectively, the sensitivity and specificity of approaches to screening and stratifying youth (under age 18) who are at risk for suicide in order to improve the overall care of these individuals in the Emergency Department (ED) setting. To optimize the generalizability of improved ED care to reduce suicidality, applications should develop screening and risk stratification approaches that can be tested across multiple general medical emergency department settings. Improved screening would inform subgroup-by-intervention pairing to increase impact and future intervention development to target modifiable risk factors within specific high risk groups. This program will use the NIH U01 Research Project Cooperative Agreements award mechanism. DEADLINE NOTE: Applications may be submitted to Grants.gov in response to this announcement on or after September 18, 2013. The deadline for receipt of optional letters of intent is September 18, 2013. The deadline for receipt of full applications is October 18, 2013, by 5:00 PM local time of applicant organization.

National Institute of Mental Health/NIH/DHHS

Deadline(s)

09/10/2013 , 10/10/2013

Review

03/11/2013

Contact

Nancy L Desmond, Ph.D., Program URL

National Institute of Mental Health (NIMH) invites applications to investigate mechanisms by which the gut microbiome modulates the development and function of brain circuits that subserve behavioral functions of direct relevance to the mission of the NIMH. Because initial colonization of the gut by microbiota occurs early in life and may influence the subsequent development and modifiability of the central nervous system, developmental studies are of particular interest. Applicants may propose to use wild-type, gnotobiotic, or specific pathogen-free model organisms and/or human cohorts. With this FOA, the NIMH encourages investigator teams to initiate hypothesis-driven research in this cross-cutting research area and to identify promising mechanistic leads for future basic and translational research that will advance the mission of the NIMH. This program will use the NIH R21/R33 Phased Innovation Award mechanism.

National Institute of Mental Health/NIH/DHHS

Deadline(s)

09/17/2013

Review

04/10/2013

Contact

Jeymohan Joseph, Ph.D., Program URL

National Institute of Mental Health (NIMH), National Institute of Allergy and Infectious Diseases (NIAID), National Institute on Drug Abuse (NIDA) and National Institute of Neurological Disorders and Stroke (NINDS) invite applications to address the problem of HIV-1 persistence focused solely on the central nervous system (CNS) of HIV-infected persons treated with Highly Active Anti-Retroviral Therapy (HAART). This FOA will support innovative research in five areas: (1) basic research to identify and characterize persistent HIV-1 in CNS derived cells such as macrophages, microglia, and/or astrocytes in the setting of suppressive anti-retroviral therapy, with or without substance use; (2) basic research to determine the mechanisms involved in the temporal establishment, maintenance, and resurgence of persistent HIV-1 in CNS in relationship to the timing of antiretroviral therapy; (3) development of physiologically relevant animal models and CNS-based cellular assays that recapitulate HIV-1 persistence and latency in the presence of effective HAART including effects of chronic substance use; (4) assessment of current and emerging eradication approaches on whether and/or how well they have successfully reactivated persistent HIV from CNS-derived cells such as macrophages, microglia and astrocytes; and (5) assessment of CNS toxicity and adverse impact of current and emerging eradication strategies. Applications ranging from basic to translational research in domestic and international settings are of interest. Multidisciplinary research teams are encouraged but not required. This FOA will use the NIH Research Project (R01) award mechanism. DEADLINE NOTE: Applications may be submitted to Grants.gov in response to this announcement on or after August 17, 2013. The deadline for receipt of optional letters of intent is August 17, 2013. The deadline for receipt of full applications is September 17, 2013, by 5:00 PM local time of applicant organization.

National Institute of Mental Health/NIH/DHHS

Deadline(s)

09/17/2013

Review

04/10/2013

Contact

Jeymohan Joseph, Ph.D., Program URL

National Institute of Mental Health (NIMH), National Institute of Allergy and Infectious Diseases (NIAID), National Institute on Drug Abuse (NIDA) and National Institute of Neurological Disorders and Stroke (NINDS) invite applications to address the problem of HIV-1 persistence focused solely on the central nervous system (CNS) of HIV-infected persons treated with Highly Active Anti-Retroviral Therapy (HAART). This FOA will support innovative research in five areas: (1) basic research to identify and characterize persistent HIV-1 in CNS derived cells such as macrophages, microglia, and/or astrocytes in the setting of suppressive anti-retroviral therapy, with or without substance use; (2) basic research to determine the mechanisms involved in the temporal establishment, maintenance, and resurgence of persistent HIV-1 in CNS in relationship to the timing of antiretroviral therapy; (3) development of physiologically relevant animal models and CNS-based cellular assays that recapitulate HIV-1 persistence and latency in the presence of effective HAART including effects of chronic substance use; (4) assessment of current and emerging eradication approaches on whether and/or how well they have successfully reactivated persistent HIV from CNS-derived cells such as macrophages, microglia and astrocytes; and (5) assessment of CNS toxicity and adverse impact of current and emerging eradication strategies. Applications ranging from basic to translational research in domestic and international settings are of interest. Multidisciplinary research teams are encouraged but not required. This FOA will use the NIH Exploratory/Developmental (R21) grant mechanism. DEADLINE NOTE: Applications may be submitted to Grants.gov in response to this announcement on or after August 17, 2013. The deadline for receipt of optional letters of intent is August 17, 2013. The deadline for receipt of full applications is September 17, 2013, by 5:00 PM local time of applicant organization.

National Institute of Neurological Disorders and Stroke/NIH/DHHS

Deadline(s)

04/01/2013 , 06/01/2013

Review

02/22/2013

Contact

Dr. Scott Janis, Program Director, Program URL

National Institute of Neurological Disorders and Stroke (NINDS) invites applications to participate as a National Clinical Coordinating Center for the NINDS Stroke Trials Network. The primary goal of this network is to maximize efficiencies to develop, promote and conduct high-quality, multi-site exploratory phase 1, 2 and confirmatory phase 3 clinical trials focused on key interventions, as well as biomarker-validation studies that are immediately preparatory to trials, in stroke prevention, treatment, and recovery with the objective to have a balanced portfolio between all three approaches. The network will include multiple regional coordinating stroke centers with strong collaborative relationships between vascular neurology, emergency medicine, interventional neuroradiology, neurosurgery, neurointensive care, neuroimaging, stroke rehabilitation, and pediatric neurology that is coordinated through separate National Clinical Coordinating and Data Management Centers. This program will use the NIH U01 Research Project Cooperative Agreements award mechanism.

National Institute of Neurological Disorders and Stroke/NIH/DHHS

Deadline(s)

08/14/2013

Review

04/10/2013

Contact

Dr. Scott Janis, Program Director, Program URL

National Institute of Neurological Disorders and Stroke (NINDS) invites applications to participate as a National Data Management Center for the NINDS Stroke Trials Network. The primary goal of this network is to maximize efficiencies to develop, promote and conduct high-quality, multi-site exploratory phase 1/2 and confirmatory phase 3 clinical trials focused on key interventions, as well as biomarker-validation studies that are immediately preparatory to trials, in stroke prevention, treatment, and recovery with the objective to have a balanced portfolio between all three approaches. The network will include multiple regional coordinating stroke centers around the U.S. representing a larger number of community stroke centers all coordinated through separate National Clinical Coordinating and Data Management Centers. This FOA will utilize the U01 Research Project Cooperative Agreements award mechanism. DEADLINE NOTE: Applications may be submitted to Grants.gov in response to this announcement on or after July 14, 2013. The deadline for receipt of optional letters of intent is July 1, 2013. The deadline for receipt of full applications is August 14, 2013, by 5:00 PM local time of applicant organization.

National Institute of Nursing Research/NIH/DHHS

Deadline(s)

05/07/2013 , 06/05/2013 , 09/07/2013 , 10/05/2013

Review

02/19/2013

Contact

Dr. Linda S. Weglicki, Ph.D., RN, MSN, Program URL

The sponsors invites applications to conduct research to reduce health disparities among minority and underserved children. Specific targeted areas of research include biobehavioral studies that incorporate multiple factors that influence child health disparities such as biological (e.g., genetics, cellular, organ systems), lifestyle factors, environmental (physical and family environments), social (e.g., peers), economic, institutional, and cultural and family influences; studies that target the specific health promotion needs of children with a known illness and/or disability; and studies that test and evaluate the comparative effectiveness of health promotion interventions conducted in traditional and nontraditional settings.

National Institute of Mental Health/NIH/DHHS

Deadline(s)

07/01/2013 , 10/05/2013 , 02/05/2014 , 06/05/2014 , 10/05/2014 , 02/05/2015 , 06/05/2015 , 10/05/2015 , 02/05/2016

Review

04/11/2013

Contact

Susan T. Azrin, Ph.D., Program URL

National Institute of Mental Health (NIMH) invites applications that test reproducible strategies for substantially reducing the duration of untreated psychosis (DUP) among persons with FEP by removing significant bottlenecks in the pathway to specialty FEP care. This FOA will use the NIH Research Project (R01) award mechanism.

National Institute of Mental Health/NIH/DHHS

Deadline(s)

07/01/2013 , 10/05/2013 , 02/05/2014 , 06/05/2014 , 10/05/2014 , 02/05/2015 , 06/05/2015 , 10/05/2015 , 02/05/2016

Review

04/11/2013

Contact

Susan T. Azrin, Ph.D., Program URL

National Institute of Mental Health (NIMH) invites applications for R34 grants that (1) identify a baseline rate of DUP in community treatment systems that include evidence-based specialty care programs for FEP; (2) map referral pathways to FEP care, (3) identify gaps and bottlenecks in the referral pathway, and (4) develop and pilot test feasible strategies for substantially reducing DUP among persons with FEP. This FOA will use the NIH R34 Clinical Trial Planning Grant Program award mechanism.

New York State Department of Health

Deadline(s)

07/30/2013

Review

04/18/2013

Contact

Bonnie Jo Brautigam - Extramural Grants Administration, Program URL

NYSTEM, the New York State Stem Cell Science Program, is charged with administering stem cell research funding based on recommendations and advice from the Empire State Stem Cell Board (ESSCB). The ESSCB wishes to stimulate and support basic, applied (mechanistic, technological), translational, pre-clinical and clinical scientific investigations on any aspect of stem cell biology that will lead to a better understanding of the unique properties of stem cells and allow their utilization to treat disease. As a result, the sponsor is soliciting applications for; Investigator Initiated Research Projects (IIRP) and Innovative, Developmental or Exploratory Activities (IDEA) in Stem Cell Research. DEADLINE NOTE: Letter of Intent is due June 5, 2013 by 5 p.m. (strongly encouraged). There will be an applicant conference at the David Axelrod Institute in Albany (or by tel-conference) at 10 a.m. June 7th. Participants must register by June 5, 2013. Questions are due June 13, 2013. Applications are due July 30, 2013 by 5 p.m.

Muscular Dystrophy Association

Deadline(s)

06/15/2013

Review

03/22/2013

Contact

grants@mdausa.org, Program URL

MDA supports research aimed at developing treatments for the muscular dystrophies and related diseases of the neuromuscular system. These are the muscular dystrophies (among which are Duchenne and Becker); motor neuron diseases (including ALS and SMA); the peripheral nerve disorders (CMT and Friedreich's ataxia); inflammatory myopathies; disorders of the neuromuscular junction; metabolic diseases of muscle as well as other myopathies.

Alzheimer’s Art Quilt Initiative

Deadline(s)

Ongoing

Review

03/28/2013

Contact

Grants@AlzQuilts.org, Program URL

Grants from $10,000 to $100,000 are available on an ongoing basis to public or private, domestic research laboratories, universities, medical centers, or hospitals conducting scientific research for the prevention, treatment, or cure of Alzheimer's disease. DEADLINE NOTE: Grants from $10,000 to $100,000 are available on an ongoing basis to qualifying research organizations until December 15, 2013. Applications must be sent electronically to Grants@AlzQuilts.org.

Kennedy's Disease Association

Deadline(s)

06/21/2013

Review

04/26/2013

Contact

info@kennedysdisease.org, Program URL

The Kennedy’s Disease Association (KDA) is planning to fund one or more research grants in the fall of 2013 to further the understanding of the pathological mechanisms of Kennedy’s Disease (Spinal Bulbar Muscular Atrophy), a defect is in the X Chromosome that makes testosterone almost a poison to an infant male's body. Since there is no treatment or cure for this defect, he will grow up not knowing when the disease will begin to attack his motor neurons and muscles.

BD Biosciences

Deadline(s)

08/01/2013

Review

05/13/2013

Contact

Program URL

BD Biosciences Stem Cell Research Grants aim to support the continuing study of embryonic, adult, and induced pluripotent stem cells to improve the understanding of both normal and disease processes.

Foundation for Progressive Supranuclear Palsy (PSP)

Deadline(s)

Ongoing

Review

03/15/2013

Contact

info@curepsp.org, Program URL

The Foundation for Progressive Supranuclear Palsy (PSP) provides support for basic and clinical research in progressive supranuclear palsy. Grants are offered in line with the Foundation's mission to increase awareness of progressive supranuclear palsy, corticobasal degeneration and related brain diseases; fund research toward cure and prevention; educate healthcare professionals; and provide support, information and hope for affected persons and their families. DEADLINE NOTE: Applications are received and reviewed on a continuing basis. Funding decisions are made by the Foundation’s Board of Directors at its quarterly meetings.

International Rett Syndrome Foundation

Deadline(s)

07/01/2013

Review

05/15/2013

Contact

admin@rettsyndrome.org, Program URL

The two year Regular Research Grants are designed to assist investigators establish hypotheses relevant to Rett syndrome research and obtain future funding from other agencies.

National Multiple Sclerosis Society

Deadline(s)

08/07/2013 , 02/06/2014

Review

05/14/2013

Contact

Bruce Bebo, PhD, Program URL

The National MS Society welcomes applications for studies related to multiple sclerosis that may serve to advance its mission of stopping MS progression, restoring function and improving quality of life, and preventing MS. The Society supports fundamental as well as applied studies, non-clinical or clinical in nature, including projects in patient management, care and rehabilitation.

The Cure Starts Now Foundation

Deadline(s)

07/31/2013

Review

05/09/2013

Contact

Dr. Gavin Baumgardner, Chairman, Program URL

In its efforts to focus on those cancers that present the greatest opportunities for an encompassing cancer cure, The Cure Starts Now Foundation awards research grants to institutions and medical professionals. Typically grants awarded have a focus on pediatric brain cancers with a specific concentration on Diffuse Intrinsic Pontine Glioma, as this was the origin of The Cure Starts Now's philosophy.

American Epilepsy Society

Deadline(s)

08/19/2013

Review

05/13/2013

Contact

Cheryl-Ann Tubby, Assistant Executive Director, Program URL

The AES and the Epilepsy Foundation are partnering to provide an opportunity for scientists to obtain support for nationwide or international networks of clinical or basic science researchers focused on understanding the causes, consequences and treatment of epilepsy. Multicenter research programs are viewed as an important venue through which investigators from around the world can establish centralized databases, common protocols, shared resources, core laboratories and exchange rapidly developing techniques and technologies. Such cooperative efforts are anticipated to hasten the speed of discovery. These funds are meant to be used to support pilot projects and hold organizational and planning sessions with representatives from each center in the planned network. These planning sessions should also be used to develop the research effort and collect results that would be used to prepare and submit a larger application for support from the Federal Government and establish the multicenter research program over the long term. Principle Investigators should be members of the Society.

American Epilepsy Society

Deadline(s)

08/19/2013

Review

05/16/2013

Contact

Cheryl Tubby, Program URL

The sponsor provides seed support for its membership to encourage innovative basic or clinical research associated with the epilepsy field. Awards of $30,000 to $50,000 will be made.

National Institute of Mental Health/NIH/DHHS

Deadline(s)

06/05/2013 , 10/05/2013

Review

05/02/2013

Contact

Lisa Gilotty, Ph.D., Program URL

The sponsors invite applications to support research designed to elucidate the etiology, epidemiology, diagnosis, treatment, and optimal means of service delivery in relation to autism spectrum disorders (ASD). Basic, clinical, and applied studies are encouraged. This program will use the NIH Research Project Grant (R01) award mechanism.

National Cancer Institute/NIH/DHHS

Deadline(s)

05/07/2013 , 06/05/2013 , 09/07/2013 , 10/05/2013 , 01/07/2014 , 02/05/2014 , 05/07/2014

Review

03/15/2013

Contact

Ann Hardy, Program URL

The sponsors invite applications that propose to study high priority bioethical challenges and issues associated with the types of biomedical, social, and behavioral research supported by the participating NIH Institutes/Centers. The Office of Behavioral and Social Sciences Research (OBSSR) joins this FOA as part of its efforts to promote research on the behavioral and social aspects of health and illness. However, only participating ICs will provide direct grant support under this FOA. This program will use the NIH Research Project (R01) award mechanism.

National Institutes of Health/DHHS

Deadline(s)

05/07/2013 , 06/05/2013 , 09/07/2013 , 10/05/2013

Review

03/13/2013

Contact

grantsinfo@od.nih.gov, Program URL

The Research Project Grant (R01) is an award to support a discrete, specified, circumscribed project to be performed by named Project Directors/Principal Investigators (PDs/PIs) in areas representing the investigators specific interests and competencies, based on the mission of the NIH, to support health-related research and development.

National Institute of Mental Health/NIH/DHHS

Deadline(s)

06/16/2013 , 09/07/2013 , 10/16/2013

Review

05/02/2013

Contact

Lisa Gilotty, Ph.D., Program URL

The sponsors invite applications to support research designed to elucidate the etiology, epidemiology, diagnosis, treatment, and optimal means of service delivery in relation to autism spectrum disorders (ASD). Basic, clinical, and applied studies are encouraged. This program will use the NIH Small Research Grant (R03) award

National Institute of Mental Health/NIH/DHHS

Deadline(s)

06/16/2013 , 09/07/2013 , 10/16/2013

Review

05/02/2013

Contact

Lisa Gilotty, Ph.D., Program URL

The sponsors invite applications to support research designed to elucidate the etiology, epidemiology, diagnosis, treatment, and optimal means of service delivery in relation to autism spectrum disorders (ASD). Basic, clinical, and applied studies are encouraged. This FOA will use the NIH Exploratory/Developmental (R21) grant mechanism.

National Institute of Arthritis & Musculoskeletal & Skin Diseases/NIH/DHHS

Deadline(s)

04/08/2013 , 08/08/2013 , 12/08/2013

Review

02/21/2013

Contact

Amanda Taylor Boyce, Ph.D., Program Officer, Program URL

The sponsor provides support to promising applicants with the potential to become productive and successful independent research investigators in scientific health-related fields relevant to the programmatic interests of the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS). NIAMS is interested in supporting additional training fellowship opportunities in muscular dystrophy research. Research supported through this funding opportunity announcement will address basic, translational or clinical studies of the muscular dystrophies, which include, but are not limited to, Duchenne, myotonic, facioscapulohumeral, and congenital muscular dystrophies. This FOA will utilize the Ruth L. Kirschstein NRSA F32 award mechanism.

Society for Neuroscience

Deadline(s)

06/05/2013

Review

03/28/2013

Contact

awards@sfn.org, Program URL

The sponsor provides an award for an outstanding neuroscientist who has made significant contributions to educating the public about the field. The award includes an honorarium of $5,000.

National Institute on Aging/NIH/DHHS

Deadline(s)

06/05/2013 , 09/07/2013 , 10/05/2013 , 01/07/2014 , 02/05/2014 , 05/07/2014 , 06/05/2014 , 09/07/2014 , 10/05/2014

Review

04/01/2013

Contact

Chanda Dutta, Ph.D., Program URL

National Institute on Aging (NIA) invites applications employing secondary analysis of existing data sets or stored biospecimens, to address clinically-related issues on aging changes influencing health across the life span, and/or on diseases and disabilities in older persons. This FOA will support activities addressing specific hypotheses in clinical aging research and/or to inform the design and implementation of future epidemiologic or human intervention studies, or current geriatric practice in maintenance of health, management of disease, and prevention of disability. Existing data sets may also be used to develop and test new statistical analytical approaches. Costs for archiving of data to be made publicly available may be included in the budget, as long as the archival activities are pertinent to the proposed secondary analyses. This FOA will use the NIH Research Project (R01) award mechanism.

National Center for Chronic Disease Prevention & Health Promo./CDC/DHHS

Deadline(s)

06/20/2013

Review

05/10/2013

Contact

Zahid Samad, MD, MPH, MBA, Program URL

CDC announces the availability of (FY) 2013 funds to implement FOA DP13-1306, Sleep and Sleep Disorders. The purpose of the FOA is to improve sleep health awareness in general population, improve provider knowledge about sleep health, expand the involvement of CDC in healthy sleep promotion and sleep disorder prevention programs, as well as collaborations to improve education and awareness about sleep hygiene. Approximately total project period funding is $1.25 million. DEADLINE NOTE: The deadline for receipt of optional letters of intent is May 20, 2013. The deadline for receipt of full applications is June 20, 2013, 11:59 p.m. U.S. Eastern Standard Time.

National Institute of Diabetes and Digestive and Kidney Diseases/NIH/DHHS

Deadline(s)

05/16/2013 , 06/16/2013 , 09/07/2013

Review

01/08/2013

Contact

Kevin D. McBryde, M.D., Program Director, Program URL

NIDDK, NIMH and ODS invite applications for support of New Investigators from backgrounds nationally underrepresented in biomedical research to conduct small research projects in the scientific mission areas of the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), the National Institute of Mental Health (NIMH) and the Office of Dietary Supplements (ODS). NIDDK, NIMH and ODS recognize the need to promote diversity in the health-related research workforce by increasing the pool of highly trained researchers from diverse backgrounds conducting research in areas of importance to these Institutes and Office. The R03 grant mechanism supports different types of projects including pilot and feasibility studies; secondary analysis of existing data; small, self-contained research projects; development of research methodology; and development of new research technology. The R03 is intended to support small research projects that can be carried out in a short period of time with limited resources with the ultimate goal of providing the preliminary data for a R01-equivalent application.

Agency for Healthcare Research and Quality/DHHS

Deadline(s)

06/16/2013 , 10/16/2013

Review

05/10/2013

Contact

Angela Nunley, Program URL

The sponsor provides support for a wide variety of research designs in order to improve the quality, safety, effectiveness, and efficiency of health care through the implementation and use of health IT. These designs include: small pilot and feasibility or self-contained health IT research projects; secondary data analysis of health IT research; and economic (prospective or retrospective) analyses of health IT implementation and use. Through economic analyses estimates of health IT implementation and use costs and benefits will be generated. This program will use the NIH Small Research Grant (R03) award mechanism.

National Institute on Aging/NIH/DHHS

Deadline(s)

05/07/2013 , 02/16/2014 , 05/07/2014

Review

02/20/2013

Contact

Lis Nielsen, Ph.D., Program URL

The sponsor invites applications to stimulate interdisciplinary aging-relevant research in the social, affective and economic neurosciences. The NIA invites applications examining social, emotional and economic behaviors of relevance to aging, using approaches that examine mechanisms and processes at both (a) the social, behavioral or psychological (emotional, cognitive, motivational) level, and (b) the neurobiological or genetic level.

American Heart Association

Deadline(s)

08/18/2013

Review

04/09/2013

Contact

aha.nsc.pst@heart.org, Program URL

This award encourages investigators to undertake or continue research in the emergent phase of acute stroke treatment and submit an abstract to the International Stroke Conference. DEADLINE NOTE: The deadline for abstract submission is August 16, 2011, 5 p.m. CDT. The deadline for the upload of award application materials is August 18, 2011, 5 p.m. CDT.

National Institute on Alcohol Abuse and Alcoholism/NIH/DHHS

Deadline(s)

09/07/2013 , 10/05/2013 , 01/07/2014 , 02/05/2014 , 05/07/2014 , 06/05/2014 , 09/07/2014 , 10/05/2014 , 01/07/2015 , 02/05/2015 , 05/07/2015 , 06/05/2015 , 09/07/2015 , 10/05/2015 , 01/07/2016 , 02/05/2016 , 05/07/2016

Review

04/15/2013

Contact

Robert C. Freeman, Ph.D., Program URL

National Institute on Alcohol Abuse and Alcoholism (NIAAA) invites applications that propose to investigate the effectiveness of structural interventions aimed at reducing the risk of HIV/AIDS transmission by changing the environment of alcohol use. Although a variety of structural and environmental interventions have been employed successfully to reduce other drinking-related problems, similar research extending into the realm of HIV/AIDS risk reduction is still in its developing stages. This FOA will utilize the NIH Research Project Grant (R01) award mechanism. DEADLINE NOTE: Applications may be submitted to Grants.gov in response to this announcement on or after August 7, 2013. The deadlines for receipt of standard R01 applications under this announcement are: February 5, June 5, and October 5 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on May 8, 2016.

National Institute on Alcohol Abuse and Alcoholism/NIH/DHHS

Deadline(s)

06/16/2013 , 09/07/2013 , 10/16/2013 , 01/07/2014 , 02/16/2014 , 05/07/2014 , 06/16/2014 , 09/07/2014 , 10/16/2014 , 01/07/2015 , 02/16/2015 , 05/07/2015 , 06/16/2015 , 09/07/2015 , 10/16/2015 , 01/07/2016 , 02/16/2016 , 05/07/2016

Review

04/15/2013

Contact

Robert C. Freeman, Ph.D., Program URL

National Institute on Alcohol Abuse and Alcoholism (NIAAA) invites applications that propose to investigate the effectiveness of structural interventions aimed at reducing the risk of HIV/AIDS transmission by changing the environment of alcohol use. Although a variety of structural and environmental interventions have been employed successfully to reduce other drinking-related problems, similar research extending into the realm of HIV/AIDS risk reduction is still in its developing stages. This FOA will use the NIH Exploratory/Developmental (R21) grant mechanism. DEADLINE NOTE: Applications may be submitted to Grants.gov in response to this announcement on or after August 7, 2013. The deadlines for receipt of standard R01 applications under this announcement are: February 5, June 5, and October 5 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually. This program will expire on May 8, 2016.

National Institute on Drug Abuse/NIH/DHHS

Deadline(s)

05/07/2013 , 09/07/2013

Review

02/27/2013

Contact

Yu (Woody) Lin, Ph.D., Program URL

The sponsors invite model-driven research to understand the ways that people make decisions about engaging in behaviors that impact the risk of acquiring or transmitting HIV, or to adhere to treatments for HIV. Decision making processes may contribute to both substance use/abuse and other HIV acquisition or transmission risks. A better understanding of decision making processes in the context of brain neural networks and their associated functions would lead to the development of better strategies to reduce the frequency of HIV-risk behaviors. Therefore, this FOA encourages applications to study 1) cognitive, motivational or emotional mechanisms and/or 2) brain neuroendocrine and reinforcement systems that related to HIV-risk behaviors or treatment non-compliance. Interdisciplinary studies that incorporate approaches from psychology, economics, anthropology, sociology, decision sciences, neuroscience and computational modeling are encouraged. This FOA for R01 applications solicits empirical, hypothesis-driven, confirmatory research and modeling approaches. This program will use the NIH Research Project (R01) award mechanism.

National Institute on Drug Abuse/NIH/DHHS

Deadline(s)

05/07/2013 , 09/07/2013

Review

02/27/2013

Contact

Yu (Woody) Lin, Ph.D., Program URL

The sponsors invite exploratory, descriptive or hypothesis-generating research to understand the ways that people make decisions about engaging in behaviors that impact the risk of acquiring or transmitting HIV, or to adhere to treatments for HIV. Decision making processes may contribute to both substance use/abuse and other HIV acquisition or transmission risks. A better understanding of decision making processes in the context of brain neural networks and their associated functions would lead to the development of better strategies to reduce the frequency of HIV-risk behaviors. Therefore, this FOA encourages applications to study 1) cognitive, motivational or emotional mechanisms and/or 2) brain neuroendocrine and reinforcement systems that related to HIV-risk behaviors or treatment non-compliance. Interdisciplinary studies that incorporate approaches from psychology, economics, anthropology, sociology, decision sciences, neuroscience and computational modeling are encouraged. This program will use the NIH Small Research Grant (R03) award mechanism.

National Institute on Drug Abuse/NIH/DHHS

Deadline(s)

05/07/2013 , 09/07/2013

Review

02/27/2013

Contact

Yu (Woody) Lin, Ph.D., Program URL

The sponsors invite applications for exploratory, descriptive or hypothesis-generating research to understand the ways that people make decisions about engaging in behaviors that impact the risk of acquiring or transmitting HIV, or to adhere to treatments for HIV. Decision making processes may contribute to both substance use/abuse and other HIV acquisition or transmission risks. A better understanding of decision making processes in the context of brain neural networks and their associated functions would lead to the development of better strategies to reduce the frequency of HIV-risk behaviors. Therefore, this FOA encourages applications to study 1) cognitive, motivational or emotional mechanisms and/or 2) brain neuroendocrine and reinforcement systems that related to HIV-risk behaviors or treatment non-compliance. Interdisciplinary studies that incorporate approaches from psychology, economics, anthropology, sociology, decision sciences, neuroscience and computational modeling are encouraged. This program will use the NIH Exploratory/Developmental (R21) grant mechanism.

Autism Speaks

Deadline(s)

12/31/2014

Review

03/01/2013

Contact

Joan New, MBA, Grants Administrator, Program URL

The Trailblazer Award supports highly novel ‘out of the box’ autism-relevant research that opens new avenues to understanding the causes, diagnosis, subtyping, prevention, treatments, and cure of autism spectrum disorders.

National Multiple Sclerosis Society

Deadline(s)

08/15/2013

Review

05/14/2013

Contact

Jennifer Stark, PhD, Director of Research Training Programs, Program URL

The Sylvia Lawry Physician Fellowship Program provides individuals with an MD or equivalent medical degree with up to 3 years of formal training, under the tutelage of an established investigator, in key elements associated with conducting clinical trials in MS.

National Institute on Drug Abuse/NIH/DHHS

Deadline(s)

05/07/2013 , 06/05/2013 , 09/07/2013 , 10/05/2013

Review

02/27/2013

Contact

Da-Yu Wu, PhD, Program Director, Program URL

The sponsor invites applications that propose to study the development of the frontal and prefrontal cortices, together with the subcortical areas of the limbic system, that play significant roles in mediating emotional and motivated behavior. This initiative is designed to support the basic neuroscience research into the fundamental mechanisms of development of the frontal and prefrontal cortices, as well as the midbrain and basal forebrain structures that mediate a number of functions related to drug abuse and psychiatric disorders including: the euphoric properties of drugs, actions of psychotherapeutic agents, and memory, cognitive and emotional functions. An additional major goal of this initiative is to understand how exposure to drugs of abuse affects the cellular and molecular mechanisms underlying nervous system development of circuits implicated in drug reward and addiction. This program will use the NIH Research Project (R01) award mechanism.

Fogarty International Center/NIH/DHHS

Deadline(s)

06/24/2013 , 07/24/2013

Review

03/13/2013

Contact

Jeanne McDermott, Program URL

National Institutes of Health (NIH) invites U.S. institutions with research collaborations at low-and middle-income country (LMIC) institutions to submit applications for training programs to strengthen the leadership and expertise in selected critical research infrastructure areas at their collaborating LMIC institutions. This FOA will utilize the NIH G11- Extramural Associate Research Development Award.

International Rett Syndrome Foundation

Deadline(s)

02/01/2013 , 07/01/2013

Review

01/10/2013

Contact

Steve Kaminsky, Ph.D., Chief Science Officer, Program URL

IRSF announces the availability of HeART (Help Accelerate RTT Therapeutics) grant awards to promote the development and testing of therapeutics to treat and reverse Rett syndrome (RTT) and its symptoms. The maximum funding level for HeART grant awards is $150,000 for two years.

Department of the Army

Deadline(s)

06/27/2013

Review

05/06/2013

Contact

cdmrp.pa@amedd.army.mil, Program URL

The TSCRP was first funded in 2002 to provide support for research of exceptional scientific merit and to promote innovative research focused on decreasing the clinical impact of tuberous sclerosis complex (TSC). Appropriations for the TSCRP from FY02 through FY12 totaled $41 million (M). The FY13 appropriation is $6M. The mission of the TSCRP is to encourage innovative research aimed at understanding the pathogenesis and manifestations of TSC to improve the lives of individuals with TSC. Within this context, the FY13 TSCRP encourages applications that address one or more of these vital program Focus Areas: Genetic, epigenetic, and non-genetic modifiers of TSC; Preclinical models and therapeutic strategies (e.g., cytotoxic agents, combination therapies); Biomarkers for early detection, prognosis, and prediction of treatment outcomes (such as serum markers, imaging, electrophysiology, prenatal testing, and pharmacogenetics); Impact of TSC manifestations in adults (e.g., care management, age-specific pathogenesis, epidemiology, renal, reproductive issues, and lymphangioleiomyomatosis [LAM]); Long-term benefits and effects of mTOR inhibitors or other agents; Novel strategies for diagnosis, treatment, and prevention of TSC manifestations including those geared toward early identification and intervention; Cellular and molecular mechanisms of TSC and LAM pathogenesis; Causes and treatment of epilepsy in TSC; Causes and treatment of TSC-associated neurocognitive disorders including cognitive impairment, and psychiatric, behavioral, and sleep disorders.

Department of the Army

Deadline(s)

06/27/2013

Review

05/06/2013

Contact

help@cdmrp.org, Program URL

The TSCRP was first funded in 2002 to provide support for research of exceptional scientific merit and to promote innovative research focused on decreasing the clinical impact of tuberous sclerosis complex (TSC). Appropriations for the TSCRP from FY02 through FY12 totaled $41 million (M). The FY13 appropriation is $6M. The mission of the TSCRP is to encourage innovative research aimed at understanding the pathogenesis and manifestations of TSC to improve the lives of individuals with TSC. Within this context, the FY13 TSCRP encourages applications that address one or more of these vital program Focus Areas: Genetic, epigenetic, and non-genetic modifiers of TSC; Preclinical models and therapeutic strategies (e.g., cytotoxic agents, combination therapies); Biomarkers for early detection, prognosis, and prediction of treatment outcomes (such as serum markers, imaging, electrophysiology, prenatal testing, and pharmacogenetics); Impact of TSC manifestations in adults (e.g., care management, age-specific pathogenesis, epidemiology, renal, reproductive issues, and lymphangioleiomyomatosis [LAM]); Long-term benefits and effects of mTOR inhibitors or other agents; Novel strategies for diagnosis, treatment, and prevention of TSC manifestations including those geared toward early identification and intervention; Cellular and molecular mechanisms of TSC and LAM pathogenesis; Causes and treatment of epilepsy in TSC; and Causes and treatment of TSC-associated neurocognitive disorders including cognitive impairment, and psychiatric, behavioral, and sleep disorders.

National Institute of Child Health and Human Development/NIH/DHHS

Deadline(s)

06/05/2013 , 10/05/2013

Review

02/25/2013

Contact

Mary Lou Oster-Granite, Ph.D., Program URL

The sponsor invites applications that propose to focus investigator-initiated research upon the factors that impact functioning and quality of life in individuals with intellectual and developmental disabilities (IDD) during adolescence. This FOA will use the NIH Research Project (R01) award mechanism.

National Institute of Child Health and Human Development/NIH/DHHS

Deadline(s)

06/16/2013 , 10/16/2013

Review

02/26/2013

Contact

Mary Lou Oster-Granite, Ph.D., Program URL

The sponsor invites applications that propose to focus investigator-initiated research upon the factors that impact functioning and quality of life in individuals with intellectual and developmental disabilities (IDD) during adolescence. This program will use the NIH Exploratory/Developmental (R21) grant mechanism.

American College of Physicians

Deadline(s)

07/01/2013

Review

04/18/2013

Contact

Meghann Williams, Program URL

This award is bestowed for distinguished contributions to the science of mental health. The awardee is required to give a lecture at the ACP Annual Meeting.

American Epilepsy Society

Deadline(s)

06/01/2013

Review

03/28/2013

Contact

M. Suzanne C. Berry, Program URL

The William G. Lennox Award, this award recognizes members of the society, usually at a senior level, who have a record of lifetime contributions and accomplishments related to epilepsy.

American Heart Association

Deadline(s)

07/10/2013

Review

04/09/2013

Contact

Tracie Mathis, Program URL

The award recognizes ongoing contributions to the investigation and management of stroke clinical science.

Society for Neuroscience

Deadline(s)

06/05/2013

Review

03/04/2013

Contact

awards@sfn.org, Program URL

The Young Investigator Award recognizes the outstanding achievements and contributions by a young neuroscientist who has recently received his or her advanced professional degree.

International Neural Network Society

Deadline(s)

06/01/2013

Review

04/18/2013

Contact

inns@reesgroupinc.com, Program URL

Up to two awards of $500 each are presented annually to individuals with no more than 5 years postdoctoral experience and who are under 40 years of age, for significant contributions in the field of Neural Networks.